Recent Additions

This page includes the documents that were newly added to the repository within the last 30 days.

All these words:

This exact word or phrase:

Any of these words:

None of these words:

Language:

Visit our Help Page for additional assistance

Select a Range:

Select a Format:

Custom Search Builder:

Custom Search Box

Visit our Help Page for additional assistance

Showing 661 - 680 of 1969 results

Racial and Ethnic Disparities in the Perceived Neighborhood Walking Environment and Self-reported Sleep Health: a Nationally Representative Sample of the United States.

Adjaye-Gbewonyo, Dzifa ;

Ng, Amanda E.

August 2025 | Sleep Health, 2025, v. 11, no. 4

To identify associations between perceived neighborhood walkability and sleep across racial and ethnic groups of US adults.Data from the 2020 National Health Interview Survey (N=27,521) were used to assess self-reported measures of walkability (pedestrian access, accessible amenities, unsafe walking conditions) and sleep (short and long duration; f ...

10/09/2026

Supporting Files

Title : Racial and Ethnic Disparities in the Perceived Neighborhood Walking Environment and Self-reported Sleep Health: a Nationally Representative Sample of the United States. Personal Author(s) : Adjaye-Gbewonyo, Dzifa;Ng, Amanda E.;Johnson, Dayna A.;Jackson, Chandra L.; Published Date : August 2025 Pages in Document : 495-505 (24 pdf pages) Source : Sleep Health, 2025, v. 11, no. 4 DOI : https://doi.org/10.1016/j.sleh.2025.01.010 Journal Title : Sleep Health
Adjaye-Gbewonyo, D., Ng, A. E., Johnson, D. A., & Jackson, C. L. (2025). Racial and Ethnic Disparities in the Perceived Neighborhood Walking Environment and Self-reported Sleep Health: a Nationally Representative Sample of the United States. Sleep Health, 11(4). https://doi.org/10.1016/j.sleh.2025.01.010

Adjaye-Gbewonyo, Dzifa, Amanda E. Ng, Dayna A. Johnson, and Chandra L. Jackson. "Racial and Ethnic Disparities in the Perceived Neighborhood Walking Environment and Self-reported Sleep Health: a Nationally Representative Sample of the United States." Sleep Health 11, no. 4 (2025). https://doi.org/10.1016/j.sleh.2025.01.010.

Adjaye-Gbewonyo, Dzifa, et al. "Racial and Ethnic Disparities in the Perceived Neighborhood Walking Environment and Self-reported Sleep Health: a Nationally Representative Sample of the United States." Sleep Health, vol. 11, no. 4, 2025. Stacks. https://doi.org/10.1016/j.sleh.2025.01.010.
Export RIS Citation Information. TY - Journal Article AU - Adjaye-Gbewonyo, Dzifa AU - Ng, Amanda E. AU - Johnson, Dayna A. AU - Jackson, Chandra L. AB - To identify associations between perceived neighborhood walkability and sleep across racial and ethnic groups of US adults. AB - Data from the 2020 National Health Interview Survey (N=27,521) were used to assess self-reported measures of walkability (pedestrian access, accessible amenities, unsafe walking conditions) and sleep (short and long duration; frequency of waking up unrested, trouble falling and staying asleep, sleep medication use). Stratified by racial and ethnic group, we calculated the age-adjusted prevalence of neighborhood walkability features and sleep measures and estimated prevalence ratios assessing associations between neighborhood walkability and sleep while adjusting for sociodemographic and health covariates. AB - The prevalence of unsafe walking conditions due to crime was lowest among non-Hispanic White adults (6.9%), and access to places to relax was lowest among non-Hispanic Black adults (72.5%). The prevalence of short sleep duration was highest among non-Hispanic Black adults (37.9%). Neighborhood environment features had differential associations with sleep when stratified by race and ethnicity. For example, walking path access was related to lower sleep medication use among non-Hispanic Asian adults (adjusted prevalence ratio (aPR): 0.42, 95% CI: 0.19-0.91) but greater use among non-Hispanic White adults (aPR: 1.24, 95% CI: 1.05-1.46). More associations were observed among non-Hispanic White adults than other groups; and the strongest magnitude of association was observed among non-Hispanic Asian adults (traffic and sleep medication aPR: 0.31, 95% CI: 0.12-0.84). AB - Associations between the neighborhood environment and sleep vary and may be inconsistent by race and ethnicity. Future research may help identify determinants. AB - Author manuscript AN - cdc:261603 C4 - PMC12353628 DO - https://doi.org/10.1016/j.sleh.2025.01.010 IS - 4 J2 - Sleep Health KW - Adolescent KW - Female KW - Environment Design KW - Walking KW - Racial Groups KW - Residence Characteristics KW - Health Status Disparities KW - Aged KW - Young Adult KW - Self Report KW - Sleep KW - Neighborhood Characteristics KW - Ethnicity KW - Male KW - Middle Aged KW - Humans KW - Health Surveys KW - Adult KW - Health disparities KW - Sleep duration KW - Sleep disturbances KW - Walkability KW - Built environment KW - National Health Interview Survey KW - Adolescent KW - Adult KW - Aged KW - Female KW - Humans KW - Male KW - Middle Aged KW - Young Adult KW - Environment Design KW - Ethnicity KW - Health Status Disparities KW - Health Surveys KW - Neighborhood Characteristics KW - Racial Groups KW - Residence Characteristics KW - Self Report KW - Sleep KW - Walking LA - eng PY - 2025 T2 - Sleep Health T2 - Sleep Health, 2025, v. 11, no. 4 TI - Racial and Ethnic Disparities in the Perceived Neighborhood Walking Environment and Self-reported Sleep Health: a Nationally Representative Sample of the United States. VL - 11 UR - https://stacks.cdc.gov/view/cdc/261603 ER -
The Sole Essential Low Molecular Weight Tropomyosin Isoform of Caenorhabditis Elegans is Essential For Pharyngeal Muscle Function.

Kimmich, Michael J. ;

Geary, Meaghan A.

December 2025 | Cytoskeleton (Hoboken, N.J.), 2025, v. 82, no. 12

Tropomyosin is an actin-binding protein that plays roles ranging from regulating muscle contraction to controlling cytokinesis and cell migration. The simple nematode Caenorhabditis elegans provides a useful model for studying the core functions of tropomyosin in an animal, having a relatively simple anatomy and a single tropomyosin gene, lev-11, t ...

10/09/2026

Supporting Files

Title : The Sole Essential Low Molecular Weight Tropomyosin Isoform of Caenorhabditis Elegans is Essential For Pharyngeal Muscle Function. Personal Author(s) : Kimmich, Michael J.;Geary, Meaghan A.;Mi-Mi, Lei;Votra, SarahBeth D.;Pellenz, Christopher D.;Sundaramurthy, Sumana;Pruyne, David; Published Date : December 2025 Pages in Document : 815-836 (40 pdf pages) Source : Cytoskeleton (Hoboken, N.J.), 2025, v. 82, no. 12 DOI : https://doi.org/10.1002/cm.22014 Journal Title : Cytoskeleton (Hoboken, N.J.)
Kimmich, M. J., Geary, M. A., Mi-Mi, L., Votra, S. D., Pellenz, C. D., Sundaramurthy, S., & Pruyne, D. (2025). The Sole Essential Low Molecular Weight Tropomyosin Isoform of Caenorhabditis Elegans is Essential For Pharyngeal Muscle Function. Cytoskeleton (Hoboken, N.J.), 82(12). https://doi.org/10.1002/cm.22014

Kimmich, Michael J., Meaghan A. Geary, Lei Mi-Mi, SarahBeth D. Votra, Christopher D. Pellenz, Sumana Sundaramurthy, and David Pruyne. "The Sole Essential Low Molecular Weight Tropomyosin Isoform of Caenorhabditis Elegans is Essential For Pharyngeal Muscle Function." Cytoskeleton (Hoboken, N.J.) 82, no. 12 (2025). https://doi.org/10.1002/cm.22014.

Kimmich, Michael J., et al. "The Sole Essential Low Molecular Weight Tropomyosin Isoform of Caenorhabditis Elegans is Essential For Pharyngeal Muscle Function." Cytoskeleton (Hoboken, N.J.), vol. 82, no. 12, 2025. Stacks. https://doi.org/10.1002/cm.22014.
Export RIS Citation Information. TY - Journal Article AU - Kimmich, Michael J. AU - Geary, Meaghan A. AU - Mi-Mi, Lei AU - Votra, SarahBeth D. AU - Pellenz, Christopher D. AU - Sundaramurthy, Sumana AU - Pruyne, David AB - Tropomyosin is an actin-binding protein that plays roles ranging from regulating muscle contraction to controlling cytokinesis and cell migration. The simple nematode Caenorhabditis elegans provides a useful model for studying the core functions of tropomyosin in an animal, having a relatively simple anatomy and a single tropomyosin gene, lev-11, that produces seven isoforms. Three higher molecular weight isoforms regulate the contraction of body wall and other muscles, but comparatively less is known of the functions of four lower molecular weight isoforms (LEV-11C, E, T, U). We demonstrate here that C. elegans can survive with a single low molecular weight isoform, LEV-11E. Mutants disrupted for LEV-11E die as young larvae, whereas mutants lacking all other short isoforms are viable, with no overt phenotype. Vertebrate low molecular weight tropomyosins are often considered "nonmuscle" isoforms, but we find LEV-11E localizes to sarcomeric thin filaments in pharyngeal muscle and co-precipitates from worm extracts with the formin FHOD-1, which is also associated with thin filaments in pharyngeal muscle. Pharyngeal sarcomere organization is grossly normal in larvae lacking LEV-11E, indicating that the tropomyosin is not required to stabilize thin filaments, but pharyngeal pumping is absent, suggesting LEV-11E regulates actomyosin activity similar to higher molecular weight sarcomeric tropomyosin isoforms. AB - Author manuscript AN - cdc:261602 C4 - PMC12353527 DO - https://doi.org/10.1002/cm.22014 IS - 12 J2 - Cytoskeleton (Hoboken, N.J.) KW - Pharyngeal Muscles KW - Animals KW - Molecular Weight KW - Caenorhabditis elegans KW - Caenorhabditis elegans Proteins KW - Sarcomeres KW - Protein Isoforms KW - Tropomyosin KW - actin KW - sarcomere KW - tropomyosin KW - muscle KW - C. elegans KW - Animals KW - Tropomyosin KW - Caenorhabditis elegans KW - Protein Isoforms KW - Caenorhabditis elegans Proteins KW - Pharyngeal Muscles KW - Molecular Weight KW - Sarcomeres LA - eng PY - 2025 T2 - Cytoskeleton (Hoboken, N.J.) T2 - Cytoskeleton (Hoboken, N.J.), 2025, v. 82, no. 12 TI - The Sole Essential Low Molecular Weight Tropomyosin Isoform of Caenorhabditis Elegans is Essential For Pharyngeal Muscle Function. VL - 82 UR - https://stacks.cdc.gov/view/cdc/261602 ER -
Efficacy and Safety of Higher Doses of Levofloxacin For Multidrug-resistant Tuberculosis: a Randomized, Placebo-controlled Phase ii Clinical Trial.

Phillips, PPJ ;

Peloquin, C.A.

July 2025 | American Journal of Respiratory and Critical Care Medicine, 2025, v. 211, no. 7

Evaluation of optimal dosing has generally been inadequate during tuberculosis (TB) drug development. Fluoroquinolones are central to TB treatment.To determine the dose of levofloxacin needed to achieve maximal efficacy and acceptable safety and tolerability as part of a multidrug TB regimen.Opti-Q was an international, multicenter, randomized, pla ...

10/09/2026

Supporting Files

Title : Efficacy and Safety of Higher Doses of Levofloxacin For Multidrug-resistant Tuberculosis: a Randomized, Placebo-controlled Phase ii Clinical Trial. Personal Author(s) : Phillips, PPJ;Peloquin, C.A.;Sterling, Timothy R.;Kaur, P.;Diacon, A.H.;Gotuzzo, Eduardo;Benator, D.;Warren, R.M.;Sikes, D.;Lecca, L.;Gandhi, N.R.;Streicher, E.M.;Dianis, N.;Eisenach, K.;Mitnick, C.D.;Horsburgh, C.R.; Corporate Authors(s) : the OptiQ study team Published Date : July 2025 Pages in Document : 1277-1287 (24 pdf pages) Source : American Journal of Respiratory and Critical Care Medicine, 2025, v. 211, no. 7 DOI : https://doi.org/10.1164/rccm.202407-1354OC Journal Title : American Journal of Respiratory and Critical Care Medicine
Phillips, P., Peloquin, C., Sterling, T. R., Kaur, P., Diacon, A., Gotuzzo, E., Benator, D., Warren, R., Sikes, D., Lecca, L., Gandhi, N., Streicher, E., Dianis, N., Eisenach, K., Mitnick, C., & Horsburgh, C. (2025). Efficacy and Safety of Higher Doses of Levofloxacin For Multidrug-resistant Tuberculosis: a Randomized, Placebo-controlled Phase ii Clinical Trial. American Journal of Respiratory and Critical Care Medicine, 211(7). https://doi.org/10.1164/rccm.202407-1354OC

Phillips, PPJ, C.A. Peloquin, Timothy R. Sterling, P. Kaur, A.H. Diacon, Eduardo Gotuzzo, and D. Benator, et al.. "Efficacy and Safety of Higher Doses of Levofloxacin For Multidrug-resistant Tuberculosis: a Randomized, Placebo-controlled Phase ii Clinical Trial." American Journal of Respiratory and Critical Care Medicine 211, no. 7 (2025). https://doi.org/10.1164/rccm.202407-1354OC.

Phillips, PPJ, et al. "Efficacy and Safety of Higher Doses of Levofloxacin For Multidrug-resistant Tuberculosis: a Randomized, Placebo-controlled Phase ii Clinical Trial." American Journal of Respiratory and Critical Care Medicine, vol. 211, no. 7, 2025. Stacks. https://doi.org/10.1164/rccm.202407-1354OC.
Export RIS Citation Information. TY - Journal Article AU - Phillips, PPJ AU - Peloquin, C.A. AU - Sterling, Timothy R. AU - Kaur, P. AU - Diacon, A.H. AU - Gotuzzo, Eduardo AU - Benator, D. AU - Warren, R.M. AU - Sikes, D. AU - Lecca, L. AU - Gandhi, N.R. AU - Streicher, E.M. AU - Dianis, N. AU - Eisenach, K. AU - Mitnick, C.D. AU - Horsburgh, C.R. A2 - the OptiQ study team AB - Evaluation of optimal dosing has generally been inadequate during tuberculosis (TB) drug development. Fluoroquinolones are central to TB treatment. AB - To determine the dose of levofloxacin needed to achieve maximal efficacy and acceptable safety and tolerability as part of a multidrug TB regimen. AB - Opti-Q was an international, multicenter, randomized, placebo-controlled phase II trial. Eligible participants with TB resistant to isoniazid and rifampicin but susceptible to fluoroquinolones were randomized to receive one of four weight-adjusted once-daily doses of levofloxacin for 24 weeks (168 doses) alongside a multidrug regimen: 11 mg/kg (750 mg), 14 mg/kg (750 mg/1,000 mg), 17 mg/kg (1,000 mg/1,250 mg) or 20 mg/kg (1,250 mg/1,500 mg). The primary efficacy outcome was time to sputum culture conversion, and the primary safety outcome was grade ≥3 adverse events (AEs). AB - A total of 111 participants were randomized from three sites in South Africa and Peru. Eighty-three (75%) had cavities on chest X-ray, 55 (50%) had a smear grading of 3+, and the median body mass index was 20.4 kg/m AB - . Median levofloxacin areas under the curve (AUCs)/minimum inhibitory concentrations were 573, 633, 918, and 1,343 across the four treatment arms. There was no difference in time to culture conversion on solid or liquid media by treatment arm (stratified log-rank AB - = 0.282), by tertile of AUC/minimum inhibitory concentration ( AB - = 0.350), or by dose received ( AB - = 0.723); 69.3%, 74.8%, 70.6%, and 78.3% exhibited culture conversion after 8 weeks on solid media, respectively, across the treatment arms; along with 64.6%, 69.5%, 52.6%, and 69.6% on liquid culture. More participants experienced a grade 3-5 AE at higher doses (37.0% and 16.0% in the highest and lowest dose groups, respectively; AB - = 0.042, Cochran-Armitage test for trend) and higher tertiles of AUC ( AB - = 0.011). AB - As part of a multidrug regimen, doses of levofloxacin >1,000 mg/d resulted in greater exposures and increased frequency of AEs but did not result in faster time to sputum culture conversion. A dose of 1,000 mg/d can achieve the target exposure in nearly all adults and was well tolerated. Clinical trial registered with www.clinicaltrials.gov (NCT01918397). AB - Author manuscript AN - cdc:261601 C4 - PMC12213226 DO - https://doi.org/10.1164/rccm.202407-1354OC IS - 7 J2 - American Journal of Respiratory and Critical Care Medicine KW - Sputum KW - Double-Blind Method KW - Levofloxacin KW - Drug Therapy, Combination KW - Antitubercular Agents KW - Female KW - Treatment Outcome KW - Tuberculosis, Multidrug-Resistant KW - Male KW - Middle Aged KW - Humans KW - Anti-Bacterial Agents KW - Dose-Response Relationship, Drug KW - Adult KW - levofloxacin KW - MDR-TB KW - TB KW - double-blind randomized controlled trial KW - Humans KW - Levofloxacin KW - Male KW - Female KW - Tuberculosis, Multidrug-Resistant KW - Adult KW - Middle Aged KW - Antitubercular Agents KW - Treatment Outcome KW - Dose-Response Relationship, Drug KW - Double-Blind Method KW - Sputum KW - Drug Therapy, Combination KW - Anti-Bacterial Agents LA - eng PY - 2025 T2 - American Journal of Respiratory and Critical Care Medicine T2 - American Journal of Respiratory and Critical Care Medicine, 2025, v. 211, no. 7 TI - Efficacy and Safety of Higher Doses of Levofloxacin For Multidrug-resistant Tuberculosis: a Randomized, Placebo-controlled Phase ii Clinical Trial. VL - 211 UR - https://stacks.cdc.gov/view/cdc/261601 ER -
Population-level Respiratory Virus-virus Interactions, Puerto Rico, 2013-2023.

Madewell, Zachary J. ;

Wong, Joshua M.

May 2025 | International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 2025, v. 154

Understanding virus-virus interactions is important for evaluating disease transmission and severity. Positive interactions suggest concurrent circulation, while negative interactions indicate reduced transmission of one virus when another is prevalent. This study examines interactions among seven respiratory viruses using a Bayesian approach that ...

10/09/2026

Supporting Files

Title : Population-level Respiratory Virus-virus Interactions, Puerto Rico, 2013-2023. Personal Author(s) : Madewell, Zachary J.;Wong, Joshua M.;Thayer, Maile B.;Rivera-Amill, Vanessa;Sainz de la Peña, Diego;Pasarell, Jorge Bertrán;Paz-Bailey, Gabriela;Adams, Laura E.;Yang, Yang; Published Date : May 2025 Pages in Document : 107878 (16 pdf pages) Source : International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 2025, v. 154 DOI : https://doi.org/10.1016/j.ijid.2025.107878 Journal Title : International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Madewell, Z. J., Wong, J. M., Thayer, M. B., Rivera-Amill, V., Sainz de la Peña, D., Pasarell, J. B., Paz-Bailey, G., Adams, L. E., & Yang, Y. (2025). Population-level Respiratory Virus-virus Interactions, Puerto Rico, 2013-2023. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 154. https://doi.org/10.1016/j.ijid.2025.107878

Madewell, Zachary J., Joshua M. Wong, Maile B. Thayer, Vanessa Rivera-Amill, Diego Sainz de la Peña, Jorge Bertrán Pasarell, Gabriela Paz-Bailey, Laura E. Adams, and Yang Yang. "Population-level Respiratory Virus-virus Interactions, Puerto Rico, 2013-2023." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases 154 (2025). https://doi.org/10.1016/j.ijid.2025.107878.

Madewell, Zachary J., et al. "Population-level Respiratory Virus-virus Interactions, Puerto Rico, 2013-2023." International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, vol. 154, 2025. Stacks. https://doi.org/10.1016/j.ijid.2025.107878.
Export RIS Citation Information. TY - Journal Article AU - Madewell, Zachary J. AU - Wong, Joshua M. AU - Thayer, Maile B. AU - Rivera-Amill, Vanessa AU - Sainz de la Peña, Diego AU - Pasarell, Jorge Bertrán AU - Paz-Bailey, Gabriela AU - Adams, Laura E. AU - Yang, Yang AB - Understanding virus-virus interactions is important for evaluating disease transmission and severity. Positive interactions suggest concurrent circulation, while negative interactions indicate reduced transmission of one virus when another is prevalent. This study examines interactions among seven respiratory viruses using a Bayesian approach that accounts for seasonality and long-term trends. AB - We analyzed data from 43,385 acute febrile illness cases in the Sentinel Enhanced Dengue Surveillance System in Puerto Rico (2013-2023). Viruses studied included influenza A (IAV), influenza B (IBV), respiratory syncytial virus (RSV), human parainfluenza viruses 1 and 3 (HPIV-1, HPIV-3), human adenovirus (HAdV), and human metapneumovirus (HMPV). Wavelet coherence analysis investigated synchronous or asynchronous viral co-variation, while a Bayesian hierarchical model estimated pairwise interactions. AB - Among 43,385 participants, 26.0% tested positive for at least one virus, with IAV (9.5%), HAdV (4.1%), RSV (3.6%), and IBV (3.6%) being most frequent. Coinfections occurred in 0.5% of cases, often involving HAdV. Wavelet coherence identified significant synchronization among RSV/HMPV, HPIV-1/HMPV, and other virus pairs, with minimal coherence during the COVID-19 pandemic. Bayesian modeling suggested five virus-virus associations: four positive (RSV/HPIV-3, HMPV/HPIV-1, IBV/HAdV, IBV/HMPV) and one negative (IAV/HAdV). However, when restricting the analysis to the prepandemic period, fewer associations remained statistically credible. AB - Respiratory viruses in Puerto Rico demonstrate patterns of co-circulation that may reflect complex interactions, but these associations appear context-dependent. Findings highlight the need for continued surveillance to better understand virus-virus dynamics and their implications for public health interventions. AB - Author manuscript AN - cdc:261600 C4 - PMC13019324 DO - https://doi.org/10.1016/j.ijid.2025.107878 J2 - International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases KW - Adolescent KW - Female KW - Virus Diseases KW - Bayes Theorem KW - Aged KW - Respiratory Tract Infections KW - Young Adult KW - Coinfection KW - Child KW - Infant KW - Seasons KW - Male KW - Middle Aged KW - Humans KW - Child, Preschool KW - Adult KW - Co-infection KW - Viral interference KW - Acute respiratory infections KW - Pathogen interactions KW - Viral synergism KW - Humans KW - Bayes Theorem KW - Respiratory Tract Infections KW - Male KW - Female KW - Adult KW - Middle Aged KW - Adolescent KW - Child, Preschool KW - Young Adult KW - Child KW - Infant KW - Coinfection KW - Aged KW - Virus Diseases KW - Seasons LA - eng PY - 2025 T2 - International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases T2 - International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 2025, v. 154 TI - Population-level Respiratory Virus-virus Interactions, Puerto Rico, 2013-2023. VL - 154 UR - https://stacks.cdc.gov/view/cdc/261600 ER -
Detecting Risk For Depression and Anxiety Symptoms Among Older Bereaved Women Using Text-based Analysis in the Nurses' Health Study II.

Hillcoat, Alexandra ;

Jeon, Elaine D.

March 2025 | American Journal of Epidemiology, 2025, v. 195, no. 5

We analyzed free-text narratives about recent bereavement experiences from 1997 women aged 55-73 years (M = 65.9, SD = 4.4) enrolled in the Nurses' Health Study II to identify associations between text characteristics and postbereavement mental health. We applied covariate-adjusted linear mixed effects models to assess the association between word ...

10/09/2026

Supporting Files

Title : Detecting Risk For Depression and Anxiety Symptoms Among Older Bereaved Women Using Text-based Analysis in the Nurses' Health Study II. Personal Author(s) : Hillcoat, Alexandra;Jeon, Elaine D.;Shrestha, Maleeka;Jha, Shaili C.;Kang, Jae H.;Rich-Edwards, Janet W.;Denckla, Christy A.; Published Date : March 2025 Pages in Document : 1210-1221 (22 pdf pages) Source : American Journal of Epidemiology, 2025, v. 195, no. 5 DOI : https://doi.org/10.1093/aje/kwaf056 Journal Title : American Journal of Epidemiology
Hillcoat, A., Jeon, E. D., Shrestha, M., Jha, S. C., Kang, J. H., Rich-Edwards, J. W., & Denckla, C. A. (2025). Detecting Risk For Depression and Anxiety Symptoms Among Older Bereaved Women Using Text-based Analysis in the Nurses' Health Study II. American Journal of Epidemiology, 195(5). https://doi.org/10.1093/aje/kwaf056

Hillcoat, Alexandra, Elaine D. Jeon, Maleeka Shrestha, Shaili C. Jha, Jae H. Kang, Janet W. Rich-Edwards, and Christy A. Denckla. "Detecting Risk For Depression and Anxiety Symptoms Among Older Bereaved Women Using Text-based Analysis in the Nurses' Health Study II." American Journal of Epidemiology 195, no. 5 (2025). https://doi.org/10.1093/aje/kwaf056.

Hillcoat, Alexandra, et al. "Detecting Risk For Depression and Anxiety Symptoms Among Older Bereaved Women Using Text-based Analysis in the Nurses' Health Study II." American Journal of Epidemiology, vol. 195, no. 5, 2025. Stacks. https://doi.org/10.1093/aje/kwaf056.
Export RIS Citation Information. TY - Journal Article AU - Hillcoat, Alexandra AU - Jeon, Elaine D. AU - Shrestha, Maleeka AU - Jha, Shaili C. AU - Kang, Jae H. AU - Rich-Edwards, Janet W. AU - Denckla, Christy A. AB - We analyzed free-text narratives about recent bereavement experiences from 1997 women aged 55-73 years (M = 65.9, SD = 4.4) enrolled in the Nurses' Health Study II to identify associations between text characteristics and postbereavement mental health. We applied covariate-adjusted linear mixed effects models to assess the association between word count and expression of positive vs negative sentiment (emotional valence) in first-person bereavement narratives and standardized Patient Health Questionnaire-4 (PHQ-4) total, anxiety, and depression symptom scores over 6 months, stratified by loss of a partner or child vs a close other. Emotional valence was quantified using the Valence Aware Dictionary and sEntiment Reasoner (VADER) algorithm. Among women bereaved of a close other, word count was positively associated with log PHQ-4 total (0.06 SD [95% CI, 0.02-0.09]), anxiety (0.05 SD [95% CI, 0.02-0.09]), and depression (0.06 SD [95 % CI, 0.03-0.09]) symptom scores. Negatively scored emotional valence was associated with elevated log PHQ-4 total (-0.05 SD [95% CI, -0.08 to -0.01]), anxiety (-0.04 SD [95% CI, -0.08 to 0.00]), and depression (-0.04 SD [95% CI, -0.07 to -0.01]) symptom scores. Estimated associations among women bereaved of a partner or child were elevated but underpowered. Qualitative approaches in epidemiologic cohorts offer promise in identifying novel characteristics associated with bereavement outcomes among older women. AB - Author manuscript AN - cdc:261599 C4 - PMC13137610 DO - https://doi.org/10.1093/aje/kwaf056 IS - 5 J2 - American Journal of Epidemiology KW - Bereavement KW - Female KW - Risk Factors KW - Aged KW - Middle Aged KW - Humans KW - Anxiety KW - Depression KW - Qualitative KW - bereavement KW - anxiety KW - depression KW - qualitative KW - Humans KW - Female KW - Bereavement KW - Aged KW - Middle Aged KW - Depression KW - Anxiety KW - Risk Factors LA - eng PY - 2025 T2 - American Journal of Epidemiology T2 - American Journal of Epidemiology, 2025, v. 195, no. 5 TI - Detecting Risk For Depression and Anxiety Symptoms Among Older Bereaved Women Using Text-based Analysis in the Nurses' Health Study II. VL - 195 UR - https://stacks.cdc.gov/view/cdc/261599 ER -
Worker Exit and Suicide and Overdose Mortality in a Cohort of Male Non-metal Mine Workers.

Colbeth, Hilary L. ;

Ferguson, Jacqueline M.

December 2024 | SSM. Mental Health, 2024, v. 6

Suicides, overdoses, and drug-related liver diseases (deaths of despair) are greatly elevated in the mining and extraction industries compared to other industries. To better understand the drivers of these deaths, we examined suicide or overdose mortality in relation to age at worker exit among a retrospective cohort of 11,009 male mine workers fro ...

10/09/2026

Supporting Files

Title : Worker Exit and Suicide and Overdose Mortality in a Cohort of Male Non-metal Mine Workers. Personal Author(s) : Colbeth, Hilary L.;Ferguson, Jacqueline M.;Picciotto, Sally;Koutros, Stella;Silverman, Debra T.;Eisen, Ellen A.; Published Date : December 2024 Pages in Document : 16 pdf pages Source : SSM. Mental Health, 2024, v. 6 DOI : https://doi.org/10.1016/j.ssmmh.2024.100336 Journal Title : SSM. Mental Health
Colbeth, H. L., Ferguson, J. M., Picciotto, S., Koutros, S., Silverman, D. T., & Eisen, E. A. (2024). Worker Exit and Suicide and Overdose Mortality in a Cohort of Male Non-metal Mine Workers. SSM. Mental Health, 6. https://doi.org/10.1016/j.ssmmh.2024.100336

Colbeth, Hilary L., Jacqueline M. Ferguson, Sally Picciotto, Stella Koutros, Debra T. Silverman, and Ellen A. Eisen. "Worker Exit and Suicide and Overdose Mortality in a Cohort of Male Non-metal Mine Workers." SSM. Mental Health 6 (2024). https://doi.org/10.1016/j.ssmmh.2024.100336.

Colbeth, Hilary L., et al. "Worker Exit and Suicide and Overdose Mortality in a Cohort of Male Non-metal Mine Workers." SSM. Mental Health, vol. 6, 2024. Stacks. https://doi.org/10.1016/j.ssmmh.2024.100336.
Export RIS Citation Information. TY - Journal Article AU - Colbeth, Hilary L. AU - Ferguson, Jacqueline M. AU - Picciotto, Sally AU - Koutros, Stella AU - Silverman, Debra T. AU - Eisen, Ellen A. AB - Suicides, overdoses, and drug-related liver diseases (deaths of despair) are greatly elevated in the mining and extraction industries compared to other industries. To better understand the drivers of these deaths, we examined suicide or overdose mortality in relation to age at worker exit among a retrospective cohort of 11,009 male mine workers from the Diesel Exhaust in Miners Study II. AB - We calculated age-adjusted mortality rates (1947-2015) and estimated hazard ratios (HRs) and 95% Confidence Intervals (CI) for suicide or overdose death in relation to age at worker exit (leaving work). The mining industry curtailed its workforce in the early 1980s due to economic downturn; therefore, separate models were fit for worker exit pre- and post-1980. AB - Suicide deaths peaked between 1980 and 1989 at 67.2 per 100,000, more than double the rate in the general population. The hazard rate for suicide or overdose was 2.56 times higher for inactive versus actively employed workers (95% CI: 1.88, 3.50). Based on 187 suicides or overdoses, associations between younger age at worker exit and suicide or overdose death were null or protective before 1980. However post-1980, those who exited between ages 30-39 years had an elevated risk of death HR = 1.33, 95% CI (0.70, 2.53) and those who exited before age 30 had a HR for suicide or overdose of 1.57 (0.83, 2.96) compared to those who exited work after age 55. AB - Worker exit may contribute to the elevated mortality from suicide or overdose among male mine workers, particularly among younger age groups. AB - Author manuscript AN - cdc:261598 C4 - PMC11905158 DO - https://doi.org/10.1016/j.ssmmh.2024.100336 J2 - SSM. Mental Health KW - Workforce KW - Retrospective Studies KW - Vehicle Emissions KW - Confidence Intervals KW - Suicide KW - Male KW - Miners KW - Humans KW - Liver Diseases KW - Deaths of despair KW - Mining KW - Job loss KW - Age-adjusted mortality rates KW - Cox proportional hazards KW - Humans KW - Male KW - Confidence Intervals KW - Miners KW - Retrospective Studies KW - Suicide KW - Vehicle Emissions KW - Liver Diseases KW - Workforce LA - eng PY - 2024 T2 - SSM. Mental Health T2 - SSM. Mental Health, 2024, v. 6 TI - Worker Exit and Suicide and Overdose Mortality in a Cohort of Male Non-metal Mine Workers. VL - 6 UR - https://stacks.cdc.gov/view/cdc/261598 ER -
Economic Outcomes of Disease Intervention Specialist-Delivered Interventions For Sexually Transmitted Infections: a Systematic Review.

Martin, Erika G. ;

Myderrizi, Arzana

September 2025 | Sexually Transmitted Diseases, 2025, v. 52, no. 9

Although numerous studies have demonstrated the effectiveness of interventions delivered by disease intervention specialists (DISs), relatively few studies have assessed their economic outcomes. We performed a systematic literature review of the cost, cost-effectiveness, and cost benefit of DIS-delivered interventions for sexually transmitted infec ...

10/09/2026

Supporting Files

Title : Economic Outcomes of Disease Intervention Specialist-Delivered Interventions For Sexually Transmitted Infections: a Systematic Review. Personal Author(s) : Martin, Erika G.;Myderrizi, Arzana;Kim, Heeun;Gift, Thomas L.;Hutchinson, Angela B.;Saldarriaga, Enrique M.;Chesson, Harrell W.; Published Date : September 2025 Pages in Document : 511-517 (16 pdf pages) Source : Sexually Transmitted Diseases, 2025, v. 52, no. 9 DOI : https://doi.org/10.1097/OLQ.0000000000002160 Journal Title : Sexually Transmitted Diseases
Martin, E. G., Myderrizi, A., Kim, H., Gift, T. L., Hutchinson, A. B., Saldarriaga, E. M., & Chesson, H. W. (2025). Economic Outcomes of Disease Intervention Specialist-Delivered Interventions For Sexually Transmitted Infections: a Systematic Review. Sexually Transmitted Diseases, 52(9). https://doi.org/10.1097/OLQ.0000000000002160

Martin, Erika G., Arzana Myderrizi, Heeun Kim, Thomas L. Gift, Angela B. Hutchinson, Enrique M. Saldarriaga, and Harrell W. Chesson. "Economic Outcomes of Disease Intervention Specialist-Delivered Interventions For Sexually Transmitted Infections: a Systematic Review." Sexually Transmitted Diseases 52, no. 9 (2025). https://doi.org/10.1097/OLQ.0000000000002160.

Martin, Erika G., et al. "Economic Outcomes of Disease Intervention Specialist-Delivered Interventions For Sexually Transmitted Infections: a Systematic Review." Sexually Transmitted Diseases, vol. 52, no. 9, 2025. Stacks. https://doi.org/10.1097/OLQ.0000000000002160.
Export RIS Citation Information. TY - Journal Article AU - Martin, Erika G. AU - Myderrizi, Arzana AU - Kim, Heeun AU - Gift, Thomas L. AU - Hutchinson, Angela B. AU - Saldarriaga, Enrique M. AU - Chesson, Harrell W. AB - Although numerous studies have demonstrated the effectiveness of interventions delivered by disease intervention specialists (DISs), relatively few studies have assessed their economic outcomes. We performed a systematic literature review of the cost, cost-effectiveness, and cost benefit of DIS-delivered interventions for sexually transmitted infections (STIs) in the United States. AB - Building on a recent systematic review of the effectiveness of DIS-delivered interventions, we reviewed economic outcomes associated with these interventions for STIs. We searched articles indexed in MEDLINE, Web of Science, CINAHL, and ProQuest from 2000 through December 2022, using these inclusion criteria: addressed an intervention of DIS-delivered interventions for STIs including partner services; United States setting; and included estimates for program cost, cost-effectiveness, or cost benefit. Findings were summarized through narrative synthesis. AB - Seven studies met the inclusion criteria. Overall, DIS-delivered interventions including STI partner services can be a cost-effective use of public health resources. In some scenarios, the cost of these interventions can be completely offset by averted medical costs. Cost and cost-effectiveness estimates of DIS-delivered interventions can vary across geographic settings and under different epidemiologic conditions. AB - Although scarce, the available evidence suggests that DIS-delivered interventions including STI partner services are an efficient use of public health resources. Health economic modeling studies are needed to facilitate conversion of intermediate cost-effectiveness outcomes (eg, cost per syphilis case identified and treated) into standard cost-effectiveness outcomes (eg, cost per quality-adjusted life year gained). AB - Author manuscript AN - cdc:261597 C4 - PMC12339215 DO - https://doi.org/10.1097/OLQ.0000000000002160 IS - 9 J2 - Sexually Transmitted Diseases KW - Sexually Transmitted Diseases KW - Humans KW - Cost-Benefit Analysis KW - Health Care Costs KW - Sexual Partners KW - sexually transmitted infections KW - disease intervention specialists KW - partner services KW - cost analysis KW - cost-effectiveness analysis KW - Humans KW - Sexually Transmitted Diseases KW - Cost-Benefit Analysis KW - Sexual Partners KW - Health Care Costs LA - eng PY - 2025 T2 - Sexually Transmitted Diseases T2 - Sexually Transmitted Diseases, 2025, v. 52, no. 9 TI - Economic Outcomes of Disease Intervention Specialist-Delivered Interventions For Sexually Transmitted Infections: a Systematic Review. VL - 52 UR - https://stacks.cdc.gov/view/cdc/261597 ER -
Routine Pharyngeal Gonorrhea Test of Cure: is It an Effective Cephalosporin-Resistant Gonorrhea Control Strategy?

Quilter, Laura A. S. ;

Horowitz, Rebekah

July 2025 | Sexually Transmitted Diseases, 2025, v. 52, no. 7

The Centers for Disease Control and Prevention recommends test of cure (TOC) for persons with pharyngeal gonorrhea (GC) 7 to 14 days after treatment. We investigated the yield and feasibility of routine pharyngeal GC TOC to detect treatment failures.During May 2021-July 2022, 4 US sexually transmitted disease clinics implemented pharyngeal GC TOC. ...

10/09/2026

Supporting Files

Title : Routine Pharyngeal Gonorrhea Test of Cure: is It an Effective Cephalosporin-Resistant Gonorrhea Control Strategy? Personal Author(s) : Quilter, Laura A. S.;Horowitz, Rebekah;Hall, Kellie;Bardier, Cortni;Bell, Jonathan;Bergstrom, Annika A.;Beverley, Jason;Cohen, Stephanie E.;Coleman, Megan;Devlin, Stephanie;Harold, Rachel;Harris, Meya;Kamis, Kevin;Khurana, Renuka;Kohn, Robert;Mettenbrink, Christie;Nishiyama, Masayo;Sankaran, Madeline;Takai, Benjamin;Velasquez, Corinne;Wendel, Karen A.;Bachmann, Laura H.;Barbee, Lindley; Published Date : July 2025 Pages in Document : 407-414 (18 pdf pages) Source : Sexually Transmitted Diseases, 2025, v. 52, no. 7 DOI : https://doi.org/10.1097/OLQ.0000000000002157 Journal Title : Sexually Transmitted Diseases
Quilter, L. A. S., Horowitz, R., Hall, K., Bardier, C., Bell, J., Bergstrom, A. A., Beverley, J., Cohen, S. E., Coleman, M., Devlin, S., Harold, R., Harris, M., Kamis, K., Khurana, R., Kohn, R., Mettenbrink, C., Nishiyama, M., Sankaran, M., Takai, B., ... Barbee, L. (2025). Routine Pharyngeal Gonorrhea Test of Cure: is It an Effective Cephalosporin-Resistant Gonorrhea Control Strategy?. Sexually Transmitted Diseases, 52(7). https://doi.org/10.1097/OLQ.0000000000002157

Quilter, Laura A. S., Rebekah Horowitz, Kellie Hall, Cortni Bardier, Jonathan Bell, Annika A. Bergstrom, and Jason Beverley, et al.. "Routine Pharyngeal Gonorrhea Test of Cure: is It an Effective Cephalosporin-Resistant Gonorrhea Control Strategy?." Sexually Transmitted Diseases 52, no. 7 (2025). https://doi.org/10.1097/OLQ.0000000000002157.

Quilter, Laura A. S., et al. "Routine Pharyngeal Gonorrhea Test of Cure: is It an Effective Cephalosporin-Resistant Gonorrhea Control Strategy?." Sexually Transmitted Diseases, vol. 52, no. 7, 2025. Stacks. https://doi.org/10.1097/OLQ.0000000000002157.
Export RIS Citation Information. TY - Journal Article AU - Quilter, Laura A. S. AU - Horowitz, Rebekah AU - Hall, Kellie AU - Bardier, Cortni AU - Bell, Jonathan AU - Bergstrom, Annika A. AU - Beverley, Jason AU - Cohen, Stephanie E. AU - Coleman, Megan AU - Devlin, Stephanie AU - Harold, Rachel AU - Harris, Meya AU - Kamis, Kevin AU - Khurana, Renuka AU - Kohn, Robert AU - Mettenbrink, Christie AU - Nishiyama, Masayo AU - Sankaran, Madeline AU - Takai, Benjamin AU - Velasquez, Corinne AU - Wendel, Karen A. AU - Bachmann, Laura H. AU - Barbee, Lindley AB - The Centers for Disease Control and Prevention recommends test of cure (TOC) for persons with pharyngeal gonorrhea (GC) 7 to 14 days after treatment. We investigated the yield and feasibility of routine pharyngeal GC TOC to detect treatment failures. AB - During May 2021-July 2022, 4 US sexually transmitted disease clinics implemented pharyngeal GC TOC. Sites collected demographic, clinical, and behavioral data on all treated pharyngeal GC and positive TOC cases. Cases were dispositioned with the suspected reason for positive TOC. To assess perceived feasibility, sites participated in qualitative interviews. AB - During the study period, 1968 pharyngeal GC infections were diagnosed. Among 1829 treated cases, 97.3% (n = 1777) received ceftriaxone and 45.7% (n = 836) returned for TOC, varying by site (range, 35.5%-70.8%). Among those with TOC, 4.7% (n = 39) were positive by nucleic acid amplification test. Of these, 48.7% had culture attempted; 6 positive TOCs (15.4%) were also positive by culture. Most positive TOCs (66.7%) were attributed to reinfection (n = 13) or false-positive results (n = 13). Six (15.4%) were treatment failures. Four failed recommended treatment and had a positive culture: 2 were susceptible to ceftriaxone and 2 did not have antimicrobial susceptibility results. Seven positive TOC (17.9%) had insufficient data to disposition. Sites perceived TOC to be feasible, although substantial resources were required. AB - Routine pharyngeal GC TOC yielded 5% positivity, although treatment failure was rare (<1%), and no cases of cephalosporin-resistant GC were identified. Low TOC return rates, limited culture collection, and limited culture yield highlight challenges to determining the cause of a positive TOC and the limitations of TOC in identifying cephalosporin resistance. AB - Author manuscript AN - cdc:261596 C4 - PMC12150349 DO - https://doi.org/10.1097/OLQ.0000000000002157 IS - 7 J2 - Sexually Transmitted Diseases KW - Adolescent KW - Ceftriaxone KW - Female KW - Gonorrhea KW - Cephalosporin Resistance KW - Treatment Failure KW - Young Adult KW - Pharyngeal Diseases KW - Neisseria gonorrhoeae KW - Cephalosporins KW - Male KW - Middle Aged KW - Humans KW - Anti-Bacterial Agents KW - Pharynx KW - Adult KW - Neisseria gonorrhoeae KW - pharyngeal gonorrhea KW - test of cure KW - antimicrobial resistance KW - Humans KW - Gonorrhea KW - Neisseria gonorrhoeae KW - Anti-Bacterial Agents KW - Male KW - Female KW - Adult KW - Cephalosporins KW - Ceftriaxone KW - Pharyngeal Diseases KW - Cephalosporin Resistance KW - Pharynx KW - Treatment Failure KW - Young Adult KW - Middle Aged KW - Adolescent LA - eng PY - 2025 T2 - Sexually Transmitted Diseases T2 - Sexually Transmitted Diseases, 2025, v. 52, no. 7 TI - Routine Pharyngeal Gonorrhea Test of Cure: is It an Effective Cephalosporin-Resistant Gonorrhea Control Strategy? VL - 52 UR - https://stacks.cdc.gov/view/cdc/261596 ER -
Factors Associated With Influenza and COVID-19 Vaccination Among Health Workers in Lao PDR, 2023.

Patthammavong, Chansay ;

Wodniak, Natalie

April 2025 | Vaccine, 2025, v. 54

Understanding vaccine uptake and related factors among health care workers is critical to successful vaccination programs. A cross-sectional survey was conducted in central, provincial, district hospitals and health centers among health workers in Lao People's Democratic Republic (PDR) in November 2023 to assess health workers' experience with infl ...

10/09/2026

Supporting Files

Title : Factors Associated With Influenza and COVID-19 Vaccination Among Health Workers in Lao PDR, 2023. Personal Author(s) : Patthammavong, Chansay;Wodniak, Natalie;Phounphenghack, Kongxay;Tengbriacheu, Chankham;Soumphonphakdy, Bandith;Phixay, Viengkhan;Vongkhamsao, Chansavang;Khanthamaly, Viengphone;Patel, Jaymin C.;Montgomery, Martha P.;McCarron, Margaret;Davis, William W.;Carlton, Julie;Bazant, Eva S.;Moen, Ann C.;Nouanthong, Phonethipsavanh; Published Date : April 2025 Pages in Document : 127006 (24 pdf pages) Source : Vaccine, 2025, v. 54 DOI : https://doi.org/10.1016/j.vaccine.2025.127006 Journal Title : Vaccine
Patthammavong, C., Wodniak, N., Phounphenghack, K., Tengbriacheu, C., Soumphonphakdy, B., Phixay, V., Vongkhamsao, C., Khanthamaly, V., Patel, J. C., Montgomery, M. P., McCarron, M., Davis, W. W., Carlton, J., Bazant, E. S., Moen, A. C., & Nouanthong, P. (2025). Factors Associated With Influenza and COVID-19 Vaccination Among Health Workers in Lao PDR, 2023. Vaccine, 54. https://doi.org/10.1016/j.vaccine.2025.127006

Patthammavong, Chansay, Natalie Wodniak, Kongxay Phounphenghack, Chankham Tengbriacheu, Bandith Soumphonphakdy, Viengkhan Phixay, and Chansavang Vongkhamsao, et al.. "Factors Associated With Influenza and COVID-19 Vaccination Among Health Workers in Lao PDR, 2023." Vaccine 54 (2025). https://doi.org/10.1016/j.vaccine.2025.127006.

Patthammavong, Chansay, et al. "Factors Associated With Influenza and COVID-19 Vaccination Among Health Workers in Lao PDR, 2023." Vaccine, vol. 54, 2025. Stacks. https://doi.org/10.1016/j.vaccine.2025.127006.
Export RIS Citation Information. TY - Journal Article AU - Patthammavong, Chansay AU - Wodniak, Natalie AU - Phounphenghack, Kongxay AU - Tengbriacheu, Chankham AU - Soumphonphakdy, Bandith AU - Phixay, Viengkhan AU - Vongkhamsao, Chansavang AU - Khanthamaly, Viengphone AU - Patel, Jaymin C. AU - Montgomery, Martha P. AU - McCarron, Margaret AU - Davis, William W. AU - Carlton, Julie AU - Bazant, Eva S. AU - Moen, Ann C. AU - Nouanthong, Phonethipsavanh AB - Understanding vaccine uptake and related factors among health care workers is critical to successful vaccination programs. A cross-sectional survey was conducted in central, provincial, district hospitals and health centers among health workers in Lao People's Democratic Republic (PDR) in November 2023 to assess health workers' experience with influenza and COVID-19 vaccination, vaccination uptake, intended uptake, and intention to recommend both vaccinations to patients in the future. Logistic regression was used to identify factors associated with these practices. Among 1228 surveyed health workers in six provinces, 55 % were nurses, assistant nurses, or midwives; 32 % were doctors or assistant doctors; and 14 % had other occupations. Overall, 77 % of respondents were female, and the median age was 34 years (interquartile range 29-42 years). Current influenza vaccination and receipt of COVID-19 booster doses were 70 % (95 % confidence interval [CI]: 62-78 %) and 90 % (95 % CI: 87-92 %), respectively. If vaccines were available for free in the future, approximately 94 % and 92 % of health workers would receive influenza and COVID-19 vaccination, respectively. Nearly all health workers would recommend influenza (98 %) and COVID-19 (95 %) vaccination to their patients. Health workers who had received influenza vaccination prior to the COVID-19 pandemic were more likely to have received current influenza vaccination (adjusted odds ratio [aOR], 95 % CI: 3.7, 2.8-4.9) and to intend to receive influenza vaccination in the future (aOR 2.7, 95 % CI: 1.1-6.8). Health workers who were vaccinated for influenza in the current season were more likely to receive COVID-19 booster doses and to intend to receive future booster doses (aOR, 95 % CI: 2.2, 1.3-3.7 and 2.5, 1.2-5.1, respectively). Intention to recommend influenza vaccination to patients was associated with the intention to recommend COVID-19 vaccination to patients, and vice versa. High acceptance for influenza and COVID-19 vaccination among health workers can support a successful vaccination program in Lao PDR. AB - Author manuscript AN - cdc:261595 C4 - PMC12210929 DO - https://doi.org/10.1016/j.vaccine.2025.127006 J2 - Vaccine KW - Female KW - Vaccination KW - SARS-CoV-2 KW - COVID-19 KW - Health Personnel KW - Influenza Vaccines KW - Cross-Sectional Studies KW - Surveys and Questionnaires KW - COVID-19 Vaccines KW - Male KW - Middle Aged KW - Humans KW - Adult KW - Influenza, Human KW - Influenza KW - COVID-19 KW - Vaccination KW - Lao PDR KW - Vaccine acceptance KW - Health workers KW - Humans KW - Female KW - Health Personnel KW - Adult KW - Male KW - COVID-19 KW - Cross-Sectional Studies KW - Influenza Vaccines KW - Influenza, Human KW - Vaccination KW - COVID-19 Vaccines KW - Middle Aged KW - SARS-CoV-2 KW - Surveys and Questionnaires LA - eng PY - 2025 T2 - Vaccine T2 - Vaccine, 2025, v. 54 TI - Factors Associated With Influenza and COVID-19 Vaccination Among Health Workers in Lao PDR, 2023. VL - 54 UR - https://stacks.cdc.gov/view/cdc/261595 ER -
Towards Equitable and Sustainable Indoor Air Quality Guidelines - a Perspective on Mandating Indoor Air Quality For Public Buildings.

Haverinen-Shaughnessy, Ulla ;

Dudzinska, Marzenna R.

March 2025 | Indoor Environments, 2025, v. 2, no. 1

A recent article published in Science urges mandatory indoor air quality (IAQ) standards in public spaces, focusing on protecting public health, especially against diseases such as COVID-19, but also IAQ in general. Given the significance of this topic to our society, this short communication aims to provide commentary on the article and further di ...

10/09/2026

Supporting Files

Title : Towards Equitable and Sustainable Indoor Air Quality Guidelines - a Perspective on Mandating Indoor Air Quality For Public Buildings. Personal Author(s) : Haverinen-Shaughnessy, Ulla;Dudzinska, Marzenna R.;Clinchard, Samy;Dimitroulopoulou, Sani;Fan, Xiaojun;Jacobs, Piet;Maula, Henna;Staszowska, Amelia;Toyinbo, Oluyemi;Park, Ju-Hyeong; Published Date : March 2025 Pages in Document : 8 pdf pages Source : Indoor Environments, 2025, v. 2, no. 1 DOI : https://doi.org/10.1016/j.indenv.2024.100070 Journal Title : Indoor Environments
Haverinen-Shaughnessy, U., Dudzinska, M. R., Clinchard, S., Dimitroulopoulou, S., Fan, X., Jacobs, P., Maula, H., Staszowska, A., Toyinbo, O., & Park, J. H. (2025). Towards Equitable and Sustainable Indoor Air Quality Guidelines - a Perspective on Mandating Indoor Air Quality For Public Buildings. Indoor Environments, 2(1). https://doi.org/10.1016/j.indenv.2024.100070

Haverinen-Shaughnessy, Ulla, Marzenna R. Dudzinska, Samy Clinchard, Sani Dimitroulopoulou, Xiaojun Fan, Piet Jacobs, Henna Maula, Amelia Staszowska, Oluyemi Toyinbo, and Ju-Hyeong Park. "Towards Equitable and Sustainable Indoor Air Quality Guidelines - a Perspective on Mandating Indoor Air Quality For Public Buildings." Indoor Environments 2, no. 1 (2025). https://doi.org/10.1016/j.indenv.2024.100070.

Haverinen-Shaughnessy, Ulla, et al. "Towards Equitable and Sustainable Indoor Air Quality Guidelines - a Perspective on Mandating Indoor Air Quality For Public Buildings." Indoor Environments, vol. 2, no. 1, 2025. Stacks. https://doi.org/10.1016/j.indenv.2024.100070.
Export RIS Citation Information. TY - Journal Article AU - Haverinen-Shaughnessy, Ulla AU - Dudzinska, Marzenna R. AU - Clinchard, Samy AU - Dimitroulopoulou, Sani AU - Fan, Xiaojun AU - Jacobs, Piet AU - Maula, Henna AU - Staszowska, Amelia AU - Toyinbo, Oluyemi AU - Park, Ju-Hyeong AB - A recent article published in Science urges mandatory indoor air quality (IAQ) standards in public spaces, focusing on protecting public health, especially against diseases such as COVID-19, but also IAQ in general. Given the significance of this topic to our society, this short communication aims to provide commentary on the article and further discuss the importance of establishing IAQ standards. Citing a lack of legislated standards globally, the authors propose numerical limits for four IAQ parameters: particulate matter (PM2.5), carbon dioxide (CO2), carbon monoxide (CO), and ventilation rate (VR). While recognizing that most of the countries do not have any mandatory IAQ standards, it is also noteworthy that IAQ regulations or guidelines exist in more than 40 countries. We like to emphasize that successful IAQ management requires recognizing, sharing, and reviewing openly available, existing regulations and guidelines, while adapting them to regional characteristics. AB - Author manuscript AN - cdc:261594 C4 - PMC11907273 DO - https://doi.org/10.1016/j.indenv.2024.100070 IS - 1 J2 - Indoor Environments KW - Air Pollution, Indoor KW - Ventilation KW - Database KW - Database KW - Indoor air pollutants KW - Regulations KW - Standards KW - Ventilation KW - Database KW - Air Pollution, Indoor KW - Ventilation LA - eng PY - 2025 T2 - Indoor Environments T2 - Indoor Environments, 2025, v. 2, no. 1 TI - Towards Equitable and Sustainable Indoor Air Quality Guidelines - a Perspective on Mandating Indoor Air Quality For Public Buildings. VL - 2 UR - https://stacks.cdc.gov/view/cdc/261594 ER -
More Diverse School Microbiota May Provide Better Protection Against Respiratory Infections For School Staff.

Park, Ju-Hyeong ;

Lemons, Angela R.

March 2025 | Building and Environment, 2025, v. 271

Our understanding of how exposure to school microbiota affects the respiratory health of staff and students in schools is limited. We examined the associations between exposure to school microbiota and respiratory and gastrointestinal infections. We performed an epidemiologic analysis of 1,529 school employees in the U.S. A questionnaire was admini ...

10/09/2026

Supporting Files

Title : More Diverse School Microbiota May Provide Better Protection Against Respiratory Infections For School Staff. Personal Author(s) : Park, Ju-Hyeong;Lemons, Angela R.;Croston, Tara L.;Roseman, Jerry;Green, Brett J.;Cox-Ganser, Jean M.; Published Date : March 2025 Pages in Document : 24 pdf pages Source : Building and Environment, 2025, v. 271 DOI : https://doi.org/10.1016/j.buildenv.2025.112657 Journal Title : Building and Environment
Park, J. H., Lemons, A. R., Croston, T. L., Roseman, J., Green, B. J., & Cox-Ganser, J. M. (2025). More Diverse School Microbiota May Provide Better Protection Against Respiratory Infections For School Staff. Building and Environment, 271. https://doi.org/10.1016/j.buildenv.2025.112657

Park, Ju-Hyeong, Angela R. Lemons, Tara L. Croston, Jerry Roseman, Brett J. Green, and Jean M. Cox-Ganser. "More Diverse School Microbiota May Provide Better Protection Against Respiratory Infections For School Staff." Building and Environment 271 (2025). https://doi.org/10.1016/j.buildenv.2025.112657.

Park, Ju-Hyeong, et al. "More Diverse School Microbiota May Provide Better Protection Against Respiratory Infections For School Staff." Building and Environment, vol. 271, 2025. Stacks. https://doi.org/10.1016/j.buildenv.2025.112657.
Export RIS Citation Information. TY - Journal Article AU - Park, Ju-Hyeong AU - Lemons, Angela R. AU - Croston, Tara L. AU - Roseman, Jerry AU - Green, Brett J. AU - Cox-Ganser, Jean M. AB - Our understanding of how exposure to school microbiota affects the respiratory health of staff and students in schools is limited. We examined the associations between exposure to school microbiota and respiratory and gastrointestinal infections. We performed an epidemiologic analysis of 1,529 school employees in the U.S. A questionnaire was administered to school staff to collect health information, and floor dust was vacuumed from 500 classrooms in 50 schools. Fungal internal transcribed spacer region and bacterial 16S amplicon sequencing were performed with extracted genomic DNA using Illumina Mi-Seq platform. The resulting DNA sequences were clustered into operational taxonomic units (OTUs). Staff were assigned the school-building-specific floor average number of bacterial or fungal OTUs from the same floor as their exposure. We used logistic regression models to estimate adjusted odds ratios of reported respiratory and gastrointestinal infections in the last 12 months. Exposure to the highest quartile in number of OTUs (Q4, highest richness) of the bacterial phyla Firmicutes or Actinobacteria was associated with 28-61% lower odds of upper or lower respiratory infections compared to the lower three quartiles (Q123). Higher Firmicutes diversity was more strongly associated with upper respiratory infections, while greater Actinobacteria diversity showed a stronger association with lower respiratory infections. Fungal diversity was not associated with any type of infection, and neither bacterial nor fungal diversity was associated with gastrointestinal infections. Our study suggests that exposure to a highly diverse bacterial microbiota in school environments may play an important role in protecting school staff against respiratory infections. AB - Author manuscript AN - cdc:261593 C4 - PMC11907276 DO - https://doi.org/10.1016/j.buildenv.2025.112657 J2 - Building and Environment KW - Schools KW - Odds Ratio KW - Microbiota KW - Respiratory Tract Infections KW - Logistic Models KW - Base Sequence KW - Surveys and Questionnaires KW - Actinobacteria KW - Dust KW - Students KW - Firmicutes KW - Genomics KW - DNA KW - Infection KW - actinobacteria and firmicutes KW - protective effects KW - microbial richness KW - school workers KW - Base Sequence KW - Logistic Models KW - Odds Ratio KW - Respiratory Tract Infections KW - Actinobacteria KW - Surveys and Questionnaires KW - Microbiota KW - Firmicutes KW - Genomics KW - Students KW - Schools KW - Dust KW - DNA LA - eng PY - 2025 T2 - Building and Environment T2 - Building and Environment, 2025, v. 271 TI - More Diverse School Microbiota May Provide Better Protection Against Respiratory Infections For School Staff. VL - 271 UR - https://stacks.cdc.gov/view/cdc/261593 ER -
Psychometric Testing of the Revised Oncology Nurses Health Behaviors Determinants Scale.

Abu-Alhaija, Dania M. ;

Al-Faraj, Hanan

June 2025 | Western Journal of Nursing Research, 2025, v. 47, no. 6

Chemotherapy exposure is an occupational risk that affects oncology nurses and is linked to several negative health consequences. Oncology nurses' adherence to chemotherapy handling guidelines is critical to protect themselves from this hazardous drug exposure. Several personal and workplace-related factors affect nurses' adherence to these guideli ...

10/09/2026

Supporting Files

Title : Psychometric Testing of the Revised Oncology Nurses Health Behaviors Determinants Scale. Personal Author(s) : Abu-Alhaija, Dania M.;Al-Faraj, Hanan;Miller, Elaine T.;Gillespie, Gordon L.; Published Date : June 2025 Pages in Document : 441-448 (16 pdf pages) Source : Western Journal of Nursing Research, 2025, v. 47, no. 6 DOI : https://doi.org/10.1177/01939459251324835 Journal Title : Western Journal of Nursing Research
Abu-Alhaija, D. M., Al-Faraj, H., Miller, E. T., & Gillespie, G. L. (2025). Psychometric Testing of the Revised Oncology Nurses Health Behaviors Determinants Scale. Western Journal of Nursing Research, 47(6). https://doi.org/10.1177/01939459251324835

Abu-Alhaija, Dania M., Hanan Al-Faraj, Elaine T. Miller, and Gordon L. Gillespie. "Psychometric Testing of the Revised Oncology Nurses Health Behaviors Determinants Scale." Western Journal of Nursing Research 47, no. 6 (2025). https://doi.org/10.1177/01939459251324835.

Abu-Alhaija, Dania M., et al. "Psychometric Testing of the Revised Oncology Nurses Health Behaviors Determinants Scale." Western Journal of Nursing Research, vol. 47, no. 6, 2025. Stacks. https://doi.org/10.1177/01939459251324835.
Export RIS Citation Information. TY - Journal Article AU - Abu-Alhaija, Dania M. AU - Al-Faraj, Hanan AU - Miller, Elaine T. AU - Gillespie, Gordon L. AB - Chemotherapy exposure is an occupational risk that affects oncology nurses and is linked to several negative health consequences. Oncology nurses' adherence to chemotherapy handling guidelines is critical to protect themselves from this hazardous drug exposure. Several personal and workplace-related factors affect nurses' adherence to these guidelines. AB - The purpose of this study was to test the psychometric properties of the revised Oncology Nurses Health Behaviors Determinants Scale (HBDS-ON) that measures factors affecting nurses' adherence to chemotherapy handling guidelines. AB - A quantitative cross-sectional design was used. One hundred twenty-three oncology nurses were recruited through convenience sampling from 2 hospital settings in the Midwest United States and through social media. Participants completed 3 online surveys: (1) the Revised Hazardous Drugs Handling Questionnaire, (2) the revised HBDS-ON, and (3) a demographic questionnaire. AB - Exploratory factor analysis revealed a conceptually reasonable 7-subscale structure of the revised HBDS-ON. The psychometric properties of the scale were supported by convergence validity, regression model testing, and internal consistency reliability. Oncology nurses reported adherence to chemotherapy handling guidelines 55% of the time. The cues to action in the workplace, nurses' perceived barriers, institutional response to chemotherapy exposure incidents, and personal protective equipment availability and accessibility were associated with oncology nurses' adherence to chemotherapy handling guidelines. AB - The revised HBDS-ON demonstrates reliability and validity and can be used to measure factors at workplace and personal levels that affect nurses' adherence to chemotherapy handling guidelines. AB - Author manuscript AN - cdc:261592 C4 - PMC12081178 DO - https://doi.org/10.1177/01939459251324835 IS - 6 J2 - Western Journal of Nursing Research KW - Occupational Exposure KW - Female KW - Reproducibility of Results KW - Psychometrics KW - Oncology Nursing KW - Cross-Sectional Studies KW - Surveys and Questionnaires KW - Antineoplastic Agents KW - Health Behavior KW - Male KW - Humans KW - Middle Aged KW - Adult KW - Adherence KW - antineoplastic agents KW - chemotherapy KW - occupational exposure KW - hazardous drugs KW - Humans KW - Psychometrics KW - Cross-Sectional Studies KW - Female KW - Surveys and Questionnaires KW - Adult KW - Oncology Nursing KW - Male KW - Middle Aged KW - Health Behavior KW - Reproducibility of Results KW - Occupational Exposure KW - Antineoplastic Agents LA - eng PY - 2025 T2 - Western Journal of Nursing Research T2 - Western Journal of Nursing Research, 2025, v. 47, no. 6 TI - Psychometric Testing of the Revised Oncology Nurses Health Behaviors Determinants Scale. VL - 47 UR - https://stacks.cdc.gov/view/cdc/261592 ER -
Exploring Well-Being Disparities: a Comparative Analysis of Urban and Rural Clinicians Using the NIOSH Worker Well-Being Questionnaire.

Lee, Nayeon ;

Baernholdt, Marianne

March 2025 | Workplace Health & Safety, 2025, v. 73, no. 8

Clinician well-being is crucial to the healthcare system, particularly during the COVID-19 pandemic, which intensified psychological distress among clinicians. This study examines well-being disparities between rural and urban clinicians using the NIOSH Worker Well-Being Questionnaire (WellBQ).A cross-sectional survey was conducted with 222 clinici ...

10/09/2026

Supporting Files

Title : Exploring Well-Being Disparities: a Comparative Analysis of Urban and Rural Clinicians Using the NIOSH Worker Well-Being Questionnaire. Personal Author(s) : Lee, Nayeon;Baernholdt, Marianne;Epstein, Beth;Bissram, Jennifer;Adapa, Karthik;Mazur, Lukasz M; Published Date : March 2025 Pages in Document : 409-420 (19 pdf pages) Source : Workplace Health & Safety, 2025, v. 73, no. 8 DOI : https://doi.org/10.1177/21650799251319366 Journal Title : Workplace Health & Safety
Lee, N., Baernholdt, M., Epstein, B., Bissram, J., Adapa, K., & Mazur, L. M. (2025). Exploring Well-Being Disparities: a Comparative Analysis of Urban and Rural Clinicians Using the NIOSH Worker Well-Being Questionnaire. Workplace Health & Safety, 73(8). https://doi.org/10.1177/21650799251319366

Lee, Nayeon, Marianne Baernholdt, Beth Epstein, Jennifer Bissram, Karthik Adapa, and Lukasz M Mazur. "Exploring Well-Being Disparities: a Comparative Analysis of Urban and Rural Clinicians Using the NIOSH Worker Well-Being Questionnaire." Workplace Health & Safety 73, no. 8 (2025). https://doi.org/10.1177/21650799251319366.

Lee, Nayeon, et al. "Exploring Well-Being Disparities: a Comparative Analysis of Urban and Rural Clinicians Using the NIOSH Worker Well-Being Questionnaire." Workplace Health & Safety, vol. 73, no. 8, 2025. Stacks. https://doi.org/10.1177/21650799251319366.
Export RIS Citation Information. TY - Journal Article AU - Lee, Nayeon AU - Baernholdt, Marianne AU - Epstein, Beth AU - Bissram, Jennifer AU - Adapa, Karthik AU - Mazur, Lukasz M AB - Clinician well-being is crucial to the healthcare system, particularly during the COVID-19 pandemic, which intensified psychological distress among clinicians. This study examines well-being disparities between rural and urban clinicians using the NIOSH Worker Well-Being Questionnaire (WellBQ). AB - A cross-sectional survey was conducted with 222 clinicians from one urban and three rural hospitals in North Carolina between September and December 2022. The WellBQ assessed well-being across five domains. Data analysis identified concerning thresholds based on positive and negative responses, with discrepancies resolved through independent reviews and focus group validation. AB - In the work evaluation and experience domain, rural hospitals reported concerns with time paucity and work overload, while urban hospitals focused on work-related fatigue and job engagement. Rural hospitals noted issues with job benefits, health programs, and schedule flexibility, whereas urban hospitals emphasized the lack of supportive work culture and management trust. Both settings reported concerns in the physical environment and safety climate domain, including sexual harassment, physical violence, and bullying. Health status concerns in rural hospitals included overall stress and poor mental health, while urban hospitals highlighted chronic health conditions and risky drinking. AB - This study identified significant well-being disparities between rural and urban clinicians, with urban hospitals showing higher concerning thresholds. Future research should refine these thresholds, explore workplace violence causes, and assess long-term impacts on clinician well-being.Applications to Practice:This study reveals significant well-being disparities between rural and urban clinicians, emphasizing the need for tailored occupational health interventions. AB - Author manuscript AN - cdc:261591 C4 - PMC12182601 DO - https://doi.org/10.1177/21650799251319366 IS - 8 J2 - Workplace Health & Safety KW - Hospitals, Rural KW - Female KW - Hospitals, Urban KW - SARS-CoV-2 KW - National Institute for Occupational Safety and Health, U.S. KW - COVID-19 KW - Job Satisfaction KW - Occupational Health KW - Cross-Sectional Studies KW - Surveys and Questionnaires KW - Male KW - Middle Aged KW - Humans KW - Adult KW - Clinicians KW - Well-being KW - The NIOSH WellBQ KW - Thresholds KW - clinicians KW - well-being KW - thresholds KW - Humans KW - Cross-Sectional Studies KW - Female KW - Male KW - Surveys and Questionnaires KW - Adult KW - COVID-19 KW - Middle Aged KW - National Institute for Occupational Safety and Health, U.S. KW - Hospitals, Rural KW - Hospitals, Urban KW - Occupational Health KW - SARS-CoV-2 KW - Job Satisfaction LA - eng PY - 2025 T2 - Workplace Health & Safety T2 - Workplace Health & Safety, 2025, v. 73, no. 8 TI - Exploring Well-Being Disparities: a Comparative Analysis of Urban and Rural Clinicians Using the NIOSH Worker Well-Being Questionnaire. VL - 73 UR - https://stacks.cdc.gov/view/cdc/261591 ER -
Applying Social Marketing Principles For Community-Based Cancer Screening Programs: Two Case Studies.

Kwon, Simona C. ;

Kranick, Julie A.

August 2025 | Health Education & Behavior : the Official Publication of the Society for Public Health Education, 2025, v. 52, no. 4

Minoritized communities often experience worse health outcomes on the cancer continuum. Mainstream strategies may have limited reach and utility to populations experiencing inequities in real-world settings. Through the combined use of community-based participatory research (CBPR) and social marketing strategies, which highlight community-centered ...

10/09/2026

Supporting Files

Title : Applying Social Marketing Principles For Community-Based Cancer Screening Programs: Two Case Studies. Personal Author(s) : Kwon, Simona C.;Kranick, Julie A.;Islam, Nadia S.;Wyatt, Laura C.;Patel, Shilpa;Alam, Gulnahar;Chebli, Perla;Ravenell, Joseph;Pong, Perry;Kim, Sara S.;Raveis, Victoria H.;Trinh-Shevrin, Chau; Published Date : August 2025 Pages in Document : 382-391 (18 pdf pages) Source : Health Education & Behavior : the Official Publication of the Society for Public Health Education, 2025, v. 52, no. 4 DOI : https://doi.org/10.1177/10901981251322806 Journal Title : Health Education & Behavior : the Official Publication of the Society for Public Health Education
Kwon, S. C., Kranick, J. A., Islam, N. S., Wyatt, L. C., Patel, S., Alam, G., Chebli, P., Ravenell, J., Pong, P., Kim, S. S., Raveis, V. H., & Trinh-Shevrin, C. (2025). Applying Social Marketing Principles For Community-Based Cancer Screening Programs: Two Case Studies. Health Education & Behavior : the Official Publication of the Society for Public Health Education, 52(4). https://doi.org/10.1177/10901981251322806

Kwon, Simona C., Julie A. Kranick, Nadia S. Islam, Laura C. Wyatt, Shilpa Patel, Gulnahar Alam, and Perla Chebli, et al.. "Applying Social Marketing Principles For Community-Based Cancer Screening Programs: Two Case Studies." Health Education & Behavior : the Official Publication of the Society for Public Health Education 52, no. 4 (2025). https://doi.org/10.1177/10901981251322806.

Kwon, Simona C., et al. "Applying Social Marketing Principles For Community-Based Cancer Screening Programs: Two Case Studies." Health Education & Behavior : the Official Publication of the Society for Public Health Education, vol. 52, no. 4, 2025. Stacks. https://doi.org/10.1177/10901981251322806.
Export RIS Citation Information. TY - Journal Article AU - Kwon, Simona C. AU - Kranick, Julie A. AU - Islam, Nadia S. AU - Wyatt, Laura C. AU - Patel, Shilpa AU - Alam, Gulnahar AU - Chebli, Perla AU - Ravenell, Joseph AU - Pong, Perry AU - Kim, Sara S. AU - Raveis, Victoria H. AU - Trinh-Shevrin, Chau AB - Minoritized communities often experience worse health outcomes on the cancer continuum. Mainstream strategies may have limited reach and utility to populations experiencing inequities in real-world settings. Through the combined use of community-based participatory research (CBPR) and social marketing strategies, which highlight community-centered and culturally adapted processes, we provide an approach to inform future intervention research across various health topics that has been successful in engaging minoritized and understudied communities. We present two case studies that used participatory social marketing principles to culturally adapt evidence-based cancer screening programs for two communities in New York City. The first program is a campaign to increase screening and vaccination for hepatitis B among Korean and Chinese American immigrants. The second is a culturally adapted program to increase breast and cervical cancer screening among a multiracial and ethnic population of Muslim women. These case studies illustrate the benefits of integrating social marketing and CBPR approaches as a key strategy when developing public health campaigns to effectively reach and influence health behaviors in partnership with communities that have been socially marginalized and historically underserved. AB - Author manuscript AN - cdc:261590 C4 - PMC12353832 DO - https://doi.org/10.1177/10901981251322806 IS - 4 J2 - Health Education & Behavior : the Official Publication of the Society for Public Health Education KW - Community-Based Participatory Research KW - Female KW - Emigrants and Immigrants KW - Mass Screening KW - Humans KW - Middle Aged KW - Early Detection of Cancer KW - Breast Neoplasms KW - Health Promotion KW - Social Marketing KW - Asian KW - Uterine Cervical Neoplasms KW - Humans KW - Female KW - Social Marketing KW - Community-Based Participatory Research KW - Early Detection of Cancer KW - Uterine Cervical Neoplasms KW - Asian KW - Breast Neoplasms KW - Health Promotion KW - Emigrants and Immigrants KW - Middle Aged KW - Mass Screening LA - eng PY - 2025 T2 - Health Education & Behavior : the Official Publication of the Society for Public Health Education T2 - Health Education & Behavior : the Official Publication of the Society for Public Health Education, 2025, v. 52, no. 4 TI - Applying Social Marketing Principles For Community-Based Cancer Screening Programs: Two Case Studies. VL - 52 UR - https://stacks.cdc.gov/view/cdc/261590 ER -
Lower Tuberculosis Incidence Among People With HIV Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: a Retrospective Cohort Study.

Sodeke, Olutomi ;

Shah, N. Sarita

September 2025 | Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 2025, v. 81, no. 2

Evidence shows that isoniazid preventive therapy (IPT) reduces tuberculosis (TB) incidence among people with human immunodeficiency virus (HIV) with additive benefit beyond antiretroviral therapy alone, but its effectiveness in settings with high multidrug-resistant TB (MDR-TB) burden is unclear. We assessed the relationship between IPT and TB inci ...

10/09/2026

Supporting Files

Title : Lower Tuberculosis Incidence Among People With HIV Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: a Retrospective Cohort Study. Personal Author(s) : Sodeke, Olutomi;Shah, N. Sarita;Pals, Sherri;Riabokon, Serhii;Samsonova, Olena;Mishara, Fadimatu;Doan, Ivan;Hetman, Larysa;Barzilay, Ezra;Podolchak, Nataliya;Da Silva, Juliana; Published Date : September 2025 Pages in Document : 314-321 (17 pdf pages) Source : Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 2025, v. 81, no. 2 DOI : https://doi.org/10.1093/cid/ciaf069 Journal Title : Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
Sodeke, O., Shah, N. S., Pals, S., Riabokon, S., Samsonova, O., Mishara, F., Doan, I., Hetman, L., Barzilay, E., Podolchak, N., & Da Silva, J. (2025). Lower Tuberculosis Incidence Among People With HIV Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: a Retrospective Cohort Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 81(2). https://doi.org/10.1093/cid/ciaf069

Sodeke, Olutomi, N. Sarita Shah, Sherri Pals, Serhii Riabokon, Olena Samsonova, Fadimatu Mishara, and Ivan Doan, et al.. "Lower Tuberculosis Incidence Among People With HIV Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: a Retrospective Cohort Study." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 81, no. 2 (2025). https://doi.org/10.1093/cid/ciaf069.

Sodeke, Olutomi, et al. "Lower Tuberculosis Incidence Among People With HIV Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: a Retrospective Cohort Study." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 81, no. 2, 2025. Stacks. https://doi.org/10.1093/cid/ciaf069.
Export RIS Citation Information. TY - Journal Article AU - Sodeke, Olutomi AU - Shah, N. Sarita AU - Pals, Sherri AU - Riabokon, Serhii AU - Samsonova, Olena AU - Mishara, Fadimatu AU - Doan, Ivan AU - Hetman, Larysa AU - Barzilay, Ezra AU - Podolchak, Nataliya AU - Da Silva, Juliana AB - Evidence shows that isoniazid preventive therapy (IPT) reduces tuberculosis (TB) incidence among people with human immunodeficiency virus (HIV) with additive benefit beyond antiretroviral therapy alone, but its effectiveness in settings with high multidrug-resistant TB (MDR-TB) burden is unclear. We assessed the relationship between IPT and TB incidence among people with HIV (PWH) in Ukraine, a high-burden (32.6%) MDR-TB setting, and whether its effectiveness is maintained among virologically suppressed persons. AB - We analyzed national surveillance data for HIV and TB collected between 2018 and 2022. Complete IPT (n = 40 733) was defined as receipt of ≥146 days of therapy and no IPT (n = 91 022) as <28 days of therapy. We modeled TB incidence and death using Poisson regression adjusting for covariates related to receipt of IPT and TB incidence. The secondary outcome was multidrug resistance, and sensitivity analyses explored the influence of virologic suppression. AB - Of 131 755 PWH who met inclusion criteria, 9089 (5.5%) died. Unadjusted TB incidence was 1.91 cases per 100 person-years in the No IPT group and 1.01 cases per 100 person-years in the Complete IPT group (adjusted incidence rate ratio [aIRR], 1.99). MDR-TB occurred in 29.1% and 30.7% of TB cases in the Complete and No IPT groups, respectively. Among virologically suppressed PWH, persons with no IPT had a higher TB incidence (aIRR, 1.38) than those who completed IPT. AB - Completing IPT as part of a public health intervention can significantly reduce TB incidence among PWH, even in settings with high-burden MDR-TB and among the virologically suppressed. AB - Author manuscript AN - cdc:261589 C4 - PMC12353380 DO - https://doi.org/10.1093/cid/ciaf069 IS - 2 J2 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America KW - Adolescent KW - Female KW - Antitubercular Agents KW - Isoniazid KW - Tuberculosis KW - Tuberculosis, Multidrug-Resistant KW - Young Adult KW - Retrospective Studies KW - Incidence KW - Male KW - Humans KW - Middle Aged KW - Adult KW - HIV Infections KW - tuberculosis KW - multidrug resistance KW - HIV KW - epidemiology KW - Humans KW - Isoniazid KW - Tuberculosis, Multidrug-Resistant KW - Antitubercular Agents KW - Incidence KW - HIV Infections KW - Male KW - Female KW - Retrospective Studies KW - Adult KW - Middle Aged KW - Young Adult KW - Adolescent KW - Tuberculosis LA - eng PY - 2025 T2 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America T2 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 2025, v. 81, no. 2 TI - Lower Tuberculosis Incidence Among People With HIV Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: a Retrospective Cohort Study. VL - 81 UR - https://stacks.cdc.gov/view/cdc/261589 ER -
A New Spotted Fever Group Rickettsia Genotype in Haemaphysalis Leporispalustris From Maine, USA.

Xu, Guang ;

Ballman, Elissa

May 2025 | Ticks and Tick-Borne Diseases, 2025, v. 16, no. 3

Spotted fever group (SFG) rickettsioses are increasingly recognized worldwide as threats to public health. Rickettsia rickettsii, Rickettsia parkeri, and Rickettsia rickettsii subspecies californica cause spotted fever rickettsioses, including Rocky Mountain spotted fever. These disease agents are transmitted to humans by various tick vectors in th ...

10/09/2026

Supporting Files

Title : A New Spotted Fever Group Rickettsia Genotype in Haemaphysalis Leporispalustris From Maine, USA. Personal Author(s) : Xu, Guang;Ballman, Elissa;Stamborski, Nolan;Siegel, Eric L.;Pearson, Patrick;Rich, Stephen M.; Published Date : May 2025 Pages in Document : 102465 (13 pdf pages) Source : Ticks and Tick-Borne Diseases, 2025, v. 16, no. 3 DOI : https://doi.org/10.1016/j.ttbdis.2025.102465 Journal Title : Ticks and Tick-Borne Diseases
Xu, G., Ballman, E., Stamborski, N., Siegel, E. L., Pearson, P., & Rich, S. M. (2025). A New Spotted Fever Group Rickettsia Genotype in Haemaphysalis Leporispalustris From Maine, USA. Ticks and Tick-Borne Diseases, 16(3). https://doi.org/10.1016/j.ttbdis.2025.102465

Xu, Guang, Elissa Ballman, Nolan Stamborski, Eric L. Siegel, Patrick Pearson, and Stephen M. Rich. "A New Spotted Fever Group Rickettsia Genotype in Haemaphysalis Leporispalustris From Maine, USA." Ticks and Tick-Borne Diseases 16, no. 3 (2025). https://doi.org/10.1016/j.ttbdis.2025.102465.

Xu, Guang, et al. "A New Spotted Fever Group Rickettsia Genotype in Haemaphysalis Leporispalustris From Maine, USA." Ticks and Tick-Borne Diseases, vol. 16, no. 3, 2025. Stacks. https://doi.org/10.1016/j.ttbdis.2025.102465.
Export RIS Citation Information. TY - Journal Article AU - Xu, Guang AU - Ballman, Elissa AU - Stamborski, Nolan AU - Siegel, Eric L. AU - Pearson, Patrick AU - Rich, Stephen M. AB - Spotted fever group (SFG) rickettsioses are increasingly recognized worldwide as threats to public health. Rickettsia rickettsii, Rickettsia parkeri, and Rickettsia rickettsii subspecies californica cause spotted fever rickettsioses, including Rocky Mountain spotted fever. These disease agents are transmitted to humans by various tick vectors in the United States. There is growing concern that other tick species, such as Haemaphysalis leporispalustris, may also transmit new and potentially unrecognized SFG rickettsial pathogens. In this study, we found that 6.1 % of 296 questing H. leporispalustris ticks (21 larvae, 260 nymphs, 9 males, and 6 females) collected from 38 towns across nine counties in Maine, USA, were positive for Rickettsia spp. Further multilocus sequence typing and phylogenetic analysis revealed that this is a new Rickettsia genotype (Rickettsia sp. ME2023) belonging to the SFG group and close to Candidatus Rickettsia lanei. Tick vectors and rickettsial species associated with SFG rickettsioses in New England warrant further investigation. Additionally, the role of H. leporispalustris in pathogen enzootic cycles and transmission requires further study. AB - Author manuscript AN - cdc:261588 C4 - PMC12137007 DO - https://doi.org/10.1016/j.ttbdis.2025.102465 IS - 3 J2 - Ticks and Tick-Borne Diseases KW - Genotype KW - Larva KW - Multilocus Sequence Typing KW - Female KW - Nymph KW - Animals KW - Male KW - Phylogeny KW - Rickettsia KW - Ixodidae KW - Arachnid Vectors KW - Spotted fever group KW - Rickettsia KW - Genotype KW - Haemaphysalis leporispalustris KW - Rickettsia rickettsii KW - Maine KW - Rickettsia KW - Animals KW - Ixodidae KW - Female KW - Genotype KW - Male KW - Phylogeny KW - Nymph KW - Larva KW - Multilocus Sequence Typing KW - Arachnid Vectors LA - eng PY - 2025 T2 - Ticks and Tick-Borne Diseases T2 - Ticks and Tick-Borne Diseases, 2025, v. 16, no. 3 TI - A New Spotted Fever Group Rickettsia Genotype in Haemaphysalis Leporispalustris From Maine, USA. VL - 16 UR - https://stacks.cdc.gov/view/cdc/261588 ER -
Comparative Effects of E-cigarette and Conventional Cigarette Smoke on In Vitro Bronchial Epithelial Cell Responses.

Pleiss, K. L. ;

Mosley, D. D.

May 2025 | Toxicology Letters, 2025, v. 407

Because of cigarette smoking, chronic lung diseases are the third leading cause of death in the United States. Electronic cigarettes (e-cig) were originally marketed as harm reduction devices for cigarette smokers due to low success rates with traditional smoking cessation methods. While several studies show that cigarette smoke causes damage to th ...

10/09/2026

Supporting Files

Title : Comparative Effects of E-cigarette and Conventional Cigarette Smoke on In Vitro Bronchial Epithelial Cell Responses. Personal Author(s) : Pleiss, K. L.;Mosley, D. D.;Bauer, C. D.;Bailey, K. L.;Ochoa, C. A.;Knoell, D. L.;Wyatt, T. A.; Published Date : May 2025 Pages in Document : 32-40 (22 pdf pages) Source : Toxicology Letters, 2025, v. 407 DOI : https://doi.org/10.1016/j.toxlet.2025.03.003 Journal Title : Toxicology Letters
Pleiss, K. L., Mosley, D. D., Bauer, C. D., Bailey, K. L., Ochoa, C. A., Knoell, D. L., & Wyatt, T. A. (2025). Comparative Effects of E-cigarette and Conventional Cigarette Smoke on In Vitro Bronchial Epithelial Cell Responses. Toxicology Letters, 407. https://doi.org/10.1016/j.toxlet.2025.03.003

Pleiss, K. L., D. D. Mosley, C. D. Bauer, K. L. Bailey, C. A. Ochoa, D. L. Knoell, and T. A. Wyatt. "Comparative Effects of E-cigarette and Conventional Cigarette Smoke on In Vitro Bronchial Epithelial Cell Responses." Toxicology Letters 407 (2025). https://doi.org/10.1016/j.toxlet.2025.03.003.

Pleiss, K. L., et al. "Comparative Effects of E-cigarette and Conventional Cigarette Smoke on In Vitro Bronchial Epithelial Cell Responses." Toxicology Letters, vol. 407, 2025. Stacks. https://doi.org/10.1016/j.toxlet.2025.03.003.
Export RIS Citation Information. TY - Journal Article AU - Pleiss, K. L. AU - Mosley, D. D. AU - Bauer, C. D. AU - Bailey, K. L. AU - Ochoa, C. A. AU - Knoell, D. L. AU - Wyatt, T. A. AB - Because of cigarette smoking, chronic lung diseases are the third leading cause of death in the United States. Electronic cigarettes (e-cig) were originally marketed as harm reduction devices for cigarette smokers due to low success rates with traditional smoking cessation methods. While several studies show that cigarette smoke causes damage to the lungs, comparative research assessing the injury profile of e-cig to traditional cigarettes is still limited. Comparative lung injury studies are crucial in determining the validity of e-cig as a harm reduction device for chronic smokers and can be used to assess the quality of alternate nicotine delivery options to reduce the morbidity and mortality caused by cigarettes. We hypothesize that exposure to JUUL to e-cig vapor produces decreased in vitro markers of lung injury in comparison to cigarette smoke extract at equivalent and higher nicotine concentrations to that from CSE. We compared the extent of injury to airway epithelial tissue from cigarettes and e-cig using various assays of cellular function, including ciliary beat frequency (CBF), wound closure, barrier function, cytokine release, and kinase activity. Cells were treated with various concentrations of Virginia Tobacco-flavored JUUL™ vapor extract (JVE) and cigarette smoke extract (CSE) either normalized for nicotine concentration or equivalent % dilutions from a 100 % stock extract. CSE stimulated cilia in the short term, but slowed cilia after several hours of exposure, whereas cells treated with JVE showed no significant changes in CBF. CSE slowed wound repair, but nicotine-equivalent doses of JVE did not significantly slow wound repair. CSE increased epithelial cell monolayer permeability and interleukin release in a concentration-dependent manner, but these were not observed with JVE treatment. Kinase activity assays revealed activation translocation of protein kinase C (PKC) activity in cells treated with CSE, but no such change in PKC activity was observed in JVE groups. The results of these in vitro assays suggest that at nicotine-equivalent doses, JVE from Virginia Tobacco-flavored JUUL does not impact the airway epithelium in the same manner as CSE. The lack of evidence for in vitro tissue injury in this study caused by JUUL™ vapor extract is not a justification for the harm posed by nicotine addiction, particularly at the high levels of nicotine contained in these products which are several times the legal limit of many countries. AB - Author manuscript AN - cdc:261587 C4 - PMC12011527 DO - https://doi.org/10.1016/j.toxlet.2025.03.003 J2 - Toxicology Letters KW - Smoke KW - Cilia KW - Epithelial Cells KW - Humans KW - E-Cigarette Vapor KW - Bronchi KW - Electronic Nicotine Delivery Systems KW - Nicotine KW - Cell Line KW - Tobacco Products KW - Cytokines KW - Cigarette KW - e-cigarette KW - vaping KW - smoking KW - lung KW - Humans KW - Electronic Nicotine Delivery Systems KW - Epithelial Cells KW - Smoke KW - Bronchi KW - Nicotine KW - E-Cigarette Vapor KW - Cytokines KW - Cilia KW - Tobacco Products KW - Cell Line LA - eng PY - 2025 T2 - Toxicology Letters T2 - Toxicology Letters, 2025, v. 407 TI - Comparative Effects of E-cigarette and Conventional Cigarette Smoke on In Vitro Bronchial Epithelial Cell Responses. VL - 407 UR - https://stacks.cdc.gov/view/cdc/261587 ER -
Interlaboratory Comparison of Serum Lipoprotein(a) Analytical Results Across Clinical Assays-Steps Toward Standardization.

Lyle, Alicia N. ;

Flores, Elias N.

July 13, 2026 | Journal of Clinical Lipidology, 2026, v. 19, no. 3

Lipoprotein(a) [Lp(a)] is an independent risk factor for cardiovascular diseases (CVD). Recent clinical guidelines recommend measuring Lp(a); however, the lack of Lp(a) assay standardization presents challenges to using common clinical decision points. Assay standardization may minimize interassay variability. This improves consistency in CVD risk ...

10/09/2026

Supporting Files

Title : Interlaboratory Comparison of Serum Lipoprotein(a) Analytical Results Across Clinical Assays-Steps Toward Standardization. Personal Author(s) : Lyle, Alicia N.;Flores, Elias N.;Coffman, Clark C.;Doty, Alex H.;Sugahara, Otoe;Kronenberg, Florian;Ruhaak, L. Renee;Cobbaert, Christa M.;Vesper, Hubert W.; Published Date : July 13, 2026 Pages in Document : 531-543 (25 pdf pages) Source : Journal of Clinical Lipidology, 2026, v. 19, no. 3 DOI : https://doi.org/10.1016/j.jacl.2025.02.010 Journal Title : Journal of Clinical Lipidology
Lyle, A. N., Flores, E. N., Coffman, C. C., Doty, A. H., Sugahara, O., Kronenberg, F., Ruhaak, L. R., Cobbaert, C. M., & Vesper, H. W. (2026). Interlaboratory Comparison of Serum Lipoprotein(a) Analytical Results Across Clinical Assays-Steps Toward Standardization. Journal of Clinical Lipidology, 19(3). https://doi.org/10.1016/j.jacl.2025.02.010

Lyle, Alicia N., Elias N. Flores, Clark C. Coffman, Alex H. Doty, Otoe Sugahara, Florian Kronenberg, L. Renee Ruhaak, Christa M. Cobbaert, and Hubert W. Vesper. "Interlaboratory Comparison of Serum Lipoprotein(a) Analytical Results Across Clinical Assays-Steps Toward Standardization." Journal of Clinical Lipidology 19, no. 3 (2026). https://doi.org/10.1016/j.jacl.2025.02.010.

Lyle, Alicia N., et al. "Interlaboratory Comparison of Serum Lipoprotein(a) Analytical Results Across Clinical Assays-Steps Toward Standardization." Journal of Clinical Lipidology, vol. 19, no. 3, 2026. Stacks. https://doi.org/10.1016/j.jacl.2025.02.010.
Export RIS Citation Information. TY - Journal Article AU - Lyle, Alicia N. AU - Flores, Elias N. AU - Coffman, Clark C. AU - Doty, Alex H. AU - Sugahara, Otoe AU - Kronenberg, Florian AU - Ruhaak, L. Renee AU - Cobbaert, Christa M. AU - Vesper, Hubert W. AB - Lipoprotein(a) [Lp(a)] is an independent risk factor for cardiovascular diseases (CVD). Recent clinical guidelines recommend measuring Lp(a); however, the lack of Lp(a) assay standardization presents challenges to using common clinical decision points. Assay standardization may minimize interassay variability. This improves consistency in CVD risk assessment and evaluations of Lp(a) therapeutic efficacy. Genetically determined size variations in the defining apolipoprotein(a) [apo(a)] protein contribute to interindividual Lp(a) heterogeneity. Individuals who express 2 apo(a) isoforms have 2 sizes of apo(a) in circulation, further contributing to Lp(a) heterogeneity. AB - The Centers for Disease Control and Prevention's Clinical Standardization Programs (CDC CSP) recently launched an Lp(a) standardization program based on the International Federation of Clinical Chemistry endorsed liquid-chromatography mass spectrometry-based reference measurement procedure (RMP). As part of this program, CDC CSP conducted an interlaboratory comparison study to evaluate current Lp(a) interassay variability and to investigate potential factors contributing to measurement variability. AB - Eight clinical laboratories measured Lp(a) in 40 individual donor serum samples and 3 serum pools. Serum samples were immunophenotyped by Western blot analysis to determine Lp(a) isoform sizes. Sample concentrations were measured in duplicate over 2 independent runs. AB - Assay-specific Lp(a) measurements demonstrated good linear correlation with the RMP. Lp(a) interassay measurement variations ranged from 3.3% to 69.1% across individual samples; however, Lp(a) interassay coefficients of variation did not increase in a concentration-dependent manner and were not correlated with Lp(a) isoform sizes. AB - This study provides new insights into Lp(a) interassay variability and assay performance in clinical laboratories that will guide future standardization efforts. AB - Author manuscript AN - cdc:261586 C4 - PMC13361100 DO - https://doi.org/10.1016/j.jacl.2025.02.010 IS - 3 J2 - Journal of Clinical Lipidology KW - Cardiovascular Diseases KW - Reproducibility of Results KW - Chromatography, Liquid KW - Lipoprotein(a) KW - Humans KW - Reference Standards KW - Lipoprotein(a) KW - apolipoproteins KW - assay comparison KW - interlaboratory comparison KW - standardization KW - Lp(a) KW - apo(a) KW - Humans KW - Lipoprotein(a) KW - Reference Standards KW - Cardiovascular Diseases KW - Reproducibility of Results KW - Chromatography, Liquid LA - eng PY - 2026 T2 - Journal of Clinical Lipidology T2 - Journal of Clinical Lipidology, 2026, v. 19, no. 3 TI - Interlaboratory Comparison of Serum Lipoprotein(a) Analytical Results Across Clinical Assays-Steps Toward Standardization. VL - 19 UR - https://stacks.cdc.gov/view/cdc/261586 ER -
Next-Generation Custom-Fit Reusable Respiratory Protective Device With Continuous Fit Monitoring - Part III: 3d Printing of Prototypes and Evaluation.

Park, Sungmee ;

Tian, Yuanqing

March 7, 2025 | Journal of the International Society for Respiratory Protection, 2025, v. 41, no. 2

Some respiratory protective devices (RPDs) such as filtering facepiece respirators (FFRs) are manufactured in discrete sizes, with some models being limited in accommodating the fit of some gender and race combinations. This study presents the development of a custom-fit RPD which conforms to a user's facial features and flexes and moves with facia ...

10/09/2026

Supporting Files

Title : Next-Generation Custom-Fit Reusable Respiratory Protective Device With Continuous Fit Monitoring - Part III: 3d Printing of Prototypes and Evaluation. Personal Author(s) : Park, Sungmee;Tian, Yuanqing;Bergman, Michael;Pollard, Jonisha;Zhuang, Ziqing;Jayaraman, Sundaresan; Published Date : March 7, 2025 Pages in Document : 1-12 (18 pdf pages) Source : Journal of the International Society for Respiratory Protection, 2025, v. 41, no. 2 DOI : https://doi.org/10.17226/25275 Journal Title : Journal of the International Society for Respiratory Protection
Park, S., Tian, Y., Bergman, M., Pollard, J., Zhuang, Z., & Jayaraman, S. (2025). Next-Generation Custom-Fit Reusable Respiratory Protective Device With Continuous Fit Monitoring - Part III: 3d Printing of Prototypes and Evaluation. Journal of the International Society for Respiratory Protection, 41(2). https://doi.org/10.17226/25275

Park, Sungmee, Yuanqing Tian, Michael Bergman, Jonisha Pollard, Ziqing Zhuang, and Sundaresan Jayaraman. "Next-Generation Custom-Fit Reusable Respiratory Protective Device With Continuous Fit Monitoring - Part III: 3d Printing of Prototypes and Evaluation." Journal of the International Society for Respiratory Protection 41, no. 2 (2025). https://doi.org/10.17226/25275.

Park, Sungmee, et al. "Next-Generation Custom-Fit Reusable Respiratory Protective Device With Continuous Fit Monitoring - Part III: 3d Printing of Prototypes and Evaluation." Journal of the International Society for Respiratory Protection, vol. 41, no. 2, 2025. Stacks. https://doi.org/10.17226/25275.
Export RIS Citation Information. TY - Journal Article AU - Park, Sungmee AU - Tian, Yuanqing AU - Bergman, Michael AU - Pollard, Jonisha AU - Zhuang, Ziqing AU - Jayaraman, Sundaresan AB - Some respiratory protective devices (RPDs) such as filtering facepiece respirators (FFRs) are manufactured in discrete sizes, with some models being limited in accommodating the fit of some gender and race combinations. This study presents the development of a custom-fit RPD which conforms to a user's facial features and flexes and moves with facial movements during use. Our design also integrates a pressure-sensing network, which continuously monitors fit and will alert the user when the fit is compromised. In this final part of the three-part series, we transform the digital prototypes of the custom-fit RPD presented in Parts I and II to physical prototypes through 3D printing (additive manufacturing) using silicone-based elastomers. We identify the key material properties required for creating the physical prototypes. Based on a comparative analysis of commercially available materials, we select two of them and create prototypes of the RPD using two different commercial 3D printers. We then demonstrate the responsiveness of the custom-fit RPD to changes in facial profile during use from natural (neutral facial expression with mouth closed) to talking, to smiling, and to yawning, and the quantification of the changes in pressure at the faceseal by the continuous fit monitoring system through an App running on an Android tablet. With the realization of the successful custom-fit RPDs using the developed methodology, we lay the foundation for providing respiratory protection, and improved source control, to the full spectrum of individuals in the United States public including children, for whom FFRs options are currently limited. AB - Author manuscript AN - cdc:261585 C4 - PMC11887481 DO - https://doi.org/10.17226/25275 IS - 2 J2 - Journal of the International Society for Respiratory Protection KW - Respiratory Protective Devices KW - Printing, Three-Dimensional KW - Ventilators, Mechanical KW - Custom-fit respiratory protective device KW - continuous fit monitoring KW - 3D printing KW - additive manufacturing KW - Shore hardness KW - protection KW - comfort KW - faceseal pressure KW - pressure injury KW - data analytics KW - facial profile KW - Respiratory Protective Devices KW - Printing, Three-Dimensional KW - Ventilators, Mechanical LA - eng PY - 2025 T2 - Journal of the International Society for Respiratory Protection T2 - Journal of the International Society for Respiratory Protection, 2025, v. 41, no. 2 TI - Next-Generation Custom-Fit Reusable Respiratory Protective Device With Continuous Fit Monitoring - Part III: 3d Printing of Prototypes and Evaluation. VL - 41 UR - https://stacks.cdc.gov/view/cdc/261585 ER -
Prevalence of Rickettsia Species Phylotype G022 and Rickettsia Tillamookensis in Ixodes Pacificus Nymphs and Adults From Northern California.

Trent, Erin ;

Swei, Andrea

May 2025 | Ticks and Tick-Borne Diseases, 2025, v. 16, no. 3

Ticks are known vectors of various pathogenic bacteria, including species of Rickettsia. Two novel Rickettsia species have been identified in adult Ixodes pacificus: Rickettsia species phylotype G022 in 2011 and R. tillamookensis in 2021. Currently, the pathogenic potential of these species found in I. pacificus remains unknown. This study aimed to ...

10/09/2026

Supporting Files

Title : Prevalence of Rickettsia Species Phylotype G022 and Rickettsia Tillamookensis in Ixodes Pacificus Nymphs and Adults From Northern California. Personal Author(s) : Trent, Erin;Swei, Andrea;Feiszli, Tina;Saunders, Megan E.M.;Zhong, Jianmin; Published Date : May 2025 Pages in Document : 102463 (17 pdf pages) Source : Ticks and Tick-Borne Diseases, 2025, v. 16, no. 3 DOI : https://doi.org/10.1016/j.ttbdis.2025.102463 Journal Title : Ticks and Tick-Borne Diseases
Trent, E., Swei, A., Feiszli, T., Saunders, M. E., & Zhong, J. (2025). Prevalence of Rickettsia Species Phylotype G022 and Rickettsia Tillamookensis in Ixodes Pacificus Nymphs and Adults From Northern California. Ticks and Tick-Borne Diseases, 16(3). https://doi.org/10.1016/j.ttbdis.2025.102463

Trent, Erin, Andrea Swei, Tina Feiszli, Megan E.M. Saunders, and Jianmin Zhong. "Prevalence of Rickettsia Species Phylotype G022 and Rickettsia Tillamookensis in Ixodes Pacificus Nymphs and Adults From Northern California." Ticks and Tick-Borne Diseases 16, no. 3 (2025). https://doi.org/10.1016/j.ttbdis.2025.102463.

Trent, Erin, et al. "Prevalence of Rickettsia Species Phylotype G022 and Rickettsia Tillamookensis in Ixodes Pacificus Nymphs and Adults From Northern California." Ticks and Tick-Borne Diseases, vol. 16, no. 3, 2025. Stacks. https://doi.org/10.1016/j.ttbdis.2025.102463.
Export RIS Citation Information. TY - Journal Article AU - Trent, Erin AU - Swei, Andrea AU - Feiszli, Tina AU - Saunders, Megan E.M. AU - Zhong, Jianmin AB - Ticks are known vectors of various pathogenic bacteria, including species of Rickettsia. Two novel Rickettsia species have been identified in adult Ixodes pacificus: Rickettsia species phylotype G022 in 2011 and R. tillamookensis in 2021. Currently, the pathogenic potential of these species found in I. pacificus remains unknown. This study aimed to determine the prevalence of phylotype G022 and R. tillamookensis in I. pacificus nymphs across different mean annual temperature and relative humidity zones in California. Adult ticks were also tested for phylotype G022. Ticks were collected from multiple locations in seven northern California counties and tested by real-time PCR. The overall prevalence of phylotype G022 and R. tillamookensis in nymphs (n = 550) was 5.3 % (95 % CI = 3.7 %-7.5 %) and 1.6 % (95 % CI=0.8 %-3.3 %), respectively. The overall prevalence of phylotype G022 in adult I. pacificus (n = 720) was 9.0 % (95 % CI = 7.2 %-11.3 %). Phylotype G022 infects nymphal I. pacificus across a broad geographic range. The prevalence of phylotype G022 was higher in the 11.7-13.3 °C (53-56°F) temperature zone, at 6.4 % (95 % CI = 4.5 %-9.2 %), compared to the 13.9-15 °C (57-59°F) zone, where the prevalence was 0.8 % (95 % CI = 0.2 %-4.6 %). In contrast, the prevalence of R. tillamookensis did not show a statistically significant difference between the two temperature zones, with 1.9 % (95 % CI = 0.9 %-4.1 % in the 11.7-13.3 °C (53-56°F) zone and 0.9 % (95 % CI = 0.2 %-4.9 %) in the 13.9-15 °C (57-59°F) zone. The detection of phylotype G022 in both questing nymphs and adults of I. pacificus suggests that it is transmitted transstadially. qPCR testing revealed no coinfections of G022 and R. tillamookensis in any of the nymphs. Although R. tillamookensis exhibited a lower overall prevalence in nymphs compared to phylotype G022, both bacteria exhibited a similar geographic distribution. AB - Author manuscript AN - cdc:261584 C4 - PMC12232624 DO - https://doi.org/10.1016/j.ttbdis.2025.102463 IS - 3 J2 - Ticks and Tick-Borne Diseases KW - Ixodes KW - Female KW - Nymph KW - Animals KW - Prevalence KW - Male KW - Rickettsia KW - Phylogeny KW - Ixodes pacificus KW - Nymphal ticks KW - Rickettsia KW - species phylotype G022 KW - Rickettsia tillamookensis KW - Animals KW - Rickettsia KW - Nymph KW - Ixodes KW - Prevalence KW - Female KW - Phylogeny KW - Male LA - eng PY - 2025 T2 - Ticks and Tick-Borne Diseases T2 - Ticks and Tick-Borne Diseases, 2025, v. 16, no. 3 TI - Prevalence of Rickettsia Species Phylotype G022 and Rickettsia Tillamookensis in Ixodes Pacificus Nymphs and Adults From Northern California. VL - 16 UR - https://stacks.cdc.gov/view/cdc/261584 ER -

Previous Page Previous

661 - 680 / 1969

Next Page Next

Found an issue?

Send us an email at: publishinghd@cdc.gov